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Impacts Of Intracellular Localizations Of Full-Length And Defective Viral
Genomes On Paramyxovirus Particle Production
Abstract
Paramyxoviruses are negative-sense single-stranded RNA viruses that comprise many important human
and animal pathogens. During viral replication, paramyxoviruses produce defective viral genomes (DVGs),
truncated genomic products that are unable to replicate in the absence of standard virus. DVGs influence
the outcomes of infection through interference with standard viral replication and by inducing antiviral
immunity. Using the model paramyxovirus, Sendai virus (SeV), we found that full-length (FL) and DVG viral
RNA (vRNA) accumulated heterogeneously in cells during infection, with some cells accumulating
predominantly full-length genomes (FL-high) and some accumulating predominantly DVGs (DVG-high).
Interestingly, in FL-high cells genomes accumulated in a perinuclear region while viral genomes in DVGhigh cells remained diffusely distributed throughout the cytoplasm. We sought to address the
mechanisms and consequences of the differential intracellular distributions of viral RNA in the presence
of DVGs. We found that vRNA in FL-high cells interacts with the host GTPase Rab11a and uses the
recycling endosome system for particle production, while viral RNA in DVG-high cells does not interact
with the host cell in this way. Consequently, FL-high cells produce both standard virions and defective
particles, while DVG-high cells do not produce virions. We next addressed the determinants of this
distinct intracellular localization. We reasoned that DVG-high cells, which robustly replicate vRNA but do
not progress to virion assembly, fail to accumulate the viral proteins required for interaction between
vRNA and Rab11a. We found that neither SeV matrix nor nucleoproteins are sufficient to drive this
interaction. We identified the viral polymerase protein L and the accessory protein C as differentiating
factors in cells that engage with Rab11a, and found C proteins to be the most enriched proteins in Rab11a
immunoprecipitation followed by mass spectrometry. These data suggest that the polymerase complex
proteins L and its cofactor C are critical in regulating initial steps in SeV assembly. Overall, this work
investigated the intracellular distributions of viral genomes in the presence of DVGs to understand the
impact of DVGs on the dynamics of full length and defective particle production, as well as to gain
insights into viral proteins required to initiate viral assembly.
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ABSTRACT
IMPACTS OF INTRACELLULAR LOCALIZATIONS OF FULL-LENGTH AND
DEFECTIVE VIRAL GENOMES ON PARAMYXOVIRUS PARTICLE PRODUCTION
Emmanuelle Genoyer
Carolina B. López
Paramyxoviruses are negative-sense single-stranded RNA viruses that comprise
many important human and animal pathogens. During viral replication, paramyxoviruses
produce defective viral genomes (DVGs), truncated genomic products that are unable to
replicate in the absence of standard virus. DVGs influence the outcomes of infection
through interference with standard viral replication and by inducing antiviral immunity.
Using the model paramyxovirus, Sendai virus (SeV), we found that full-length (FL) and
DVG viral RNA (vRNA) accumulated heterogeneously in cells during infection, with
some cells accumulating predominantly full-length genomes (FL-high) and some
accumulating predominantly DVGs (DVG-high). Interestingly, in FL-high cells genomes
accumulated in a perinuclear region while viral genomes in DVG-high cells remained
diffusely distributed throughout the cytoplasm. We sought to address the mechanisms
and consequences of the differential intracellular distributions of viral RNA in the
presence of DVGs. We found that vRNA in FL-high cells interacts with the host GTPase
Rab11a and uses the recycling endosome system for particle production, while viral
RNA in DVG-high cells does not interact with the host cell in this way. Consequently, FLhigh cells produce both standard virions and defective particles, while DVG-high cells do
not produce virions. We next addressed the determinants of this distinct intracellular
localization. We reasoned that DVG-high cells, which robustly replicate vRNA but do not
progress to virion assembly, fail to accumulate the viral proteins required for interaction
vi

between vRNA and Rab11a. We found that neither SeV matrix nor nucleoproteins are
sufficient to drive this interaction. We identified the viral polymerase protein L and the
accessory protein C as differentiating factors in cells that engage with Rab11a, and
found C proteins to be the most enriched proteins in Rab11a immunoprecipitation
followed by mass spectrometry. These data suggest that the polymerase complex
proteins L and its cofactor C are critical in regulating initial steps in SeV assembly.
Overall, this work investigated the intracellular distributions of viral genomes in the
presence of DVGs to understand the impact of DVGs on the dynamics of full length and
defective particle production, as well as to gain insights into viral proteins required to
initiate viral assembly.
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CHAPTER 1: Introduction

A portion of this chapter has been published as:
Genoyer E, López CB. 2019. The Impact of Defective Viruses on Infection and
Immunity. Annu Rev Virol 6:547-566.
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1.1 Paramyxoviruses
1.1.1 Paramyxoviruses in human and animal disease
Paramyxoviruses are negative-sense single-stranded RNA viruses that infect a
wide range of animals causing a broad spectrum of diseases. Paramyxoviruses
comprise many important human and animal pathogens that have high global burdens of
morbidity and mortality. Some paramyxoviruses including measles, mumps, Rinderpest,
and Newcastle Disease Virus are vaccine preventable or have been eradicated (1).
However, among paramyxoviruses there are a number of human pathogens which
currently lack vaccines and cause a human health burden. These include the human
parainfluenza viruses (HPIV), which include the respirovirus genus members HPIV1 and
HPIV3, and the rubulavirus genus members HPIV2 and HPIV4. These viruses circulate
in the summer and fall of alternating years and cause disease in young children. HPIV1
and HPIV2 are the leading cause of croup in young children and HPIV3 is associated
with bronchiolitis, bronchitis, and pneumonia(2). These infections have also been
associated with the development or exacerbation of asthma and chronic airway
disorders(3). Additionally, a study in 2015 demonstrated that HPIVs were the etiological
agent of 7% of hospitalized pneumonia cases in U.S. children(4), and a study of children
across five countries in Africa and Asia recapitulated these data in 2018(5). Importantly,
there are no direct acting antivirals or prophylactic vaccines for these viruses.
Additionally, there are a number of zoonotic or epizootic paramyxoviruses which
have caused small outbreaks in human populations for the past three decades and
continue to pose a threat as emerging viruses. The viruses in the henipavirus genus,
Hendra virus and Nipah virus, have caused a number of outbreaks with high case fatality
rates since the 1990s. Henipaviruses circulate in bats and while little is known about
these viruses in bats, they are not thought to cause severe disease in their host species.
2

However, spillover to human populations has proved deadly(6). Hendra virus (HeV) can
cause fatal neurological disease in horses and in humans. HeV first appeared in
Australia in 1994 and has since caused over 100 equine deaths and 7 human deaths,
with spillovers being observed at least once a year(6, 7). While there is evidence that the
virus may be transmitted from horse to human there is little evidence of sustained
human to human transmission. Additionally, while there is now an efficacious vaccine for
horses, there is no approved human vaccine(8). Nipah virus (NiV) was first identified in
1998 in an outbreak in Malaysia and Singapore(9). Since then it has crossed from bats
to humans a number of times, presumably via consumption of fruits contaminated with
bat urine or feces(9). Unlike HeV, NiV outbreaks have been partially driven by human to
human transmission, with some outbreaks recording up to 75% of cases due to human
to human transmission chains (6). These outbreaks have had high case fatality rates
with some outbreaks reaching a case fatality rate of nearly 95% and there are no
approved vaccines or direct acting antivirals(10). A number of other viruses in the
henipavirus family that currently circulate in bats are being monitored for their potential
transmission to humans, including Cedar virus. Additionally, other paramyxovirus
genuses include viruses that circulate in bats, such as the rubulavirus Sosuga virus, and
Beilong virus which belongs to its own genus, have shown limited transmissions to
humans and are also monitored for their potential to spark outbreaks in human
populations(11).
Finally, while vaccines were developed against measles and mumps in the
1950s, and by 1971 there was a licensed combination measles, mumps, and Rubella
vaccine licensed in the United States that shows 93% efficacy against measles and 88%
efficacy against mumps after two doses(12), challenges with vaccine adherence and
3

distribution have continued to leave people vulnerable to measles virus infection.
Additionally, waning humoral immunity to the mumps vaccine, even in fully immunized
populations, has led to periodic outbreaks(13). Further, Newcastle disease virus, also
known as avian avulavirus 1, which affects poultry and can be economically devastating
when livestock are infected. While there is an effective vaccine against NDV, not all
animals are vaccinated and there continue to be periodic outbreaks of this virus. Thus,
even in the presence of effective vaccines, these diseases continue to cause economic
and health burdens across the world.
With currently circulating paramyxovirus infections in humans that cause a
significant health burden, as well as potential zoonotic paramyxoviruses that lack
vaccines or treatments, it is particularly important to continue to study the basic biology
of these viruses. Understanding how the virus interacts with the host during infection can
yield various therapeutic targets that are either host or virus directed.
1.1.2 Paramyxovirus Replication
1.1.2.1. Viral genes and genomic replication
Paramyxoviruses are negative-sense single-stranded RNA viruses, which means
that their genomic RNA must be transcribed to positive-sense mRNA before being
translated in cells and the virus relies on a positive-sense intermediate antigenome for
replication (14). Paramyxoviruses code for six essential genes and a number of
accessory proteins. The six genes that comprise the essential genes of paramyxoviruses
in their order on the genome are as follows (Fig 1.1A). 1) The nucleoprotein (NP) is the
most abundant protein product and coats the viral genome during replication and within
the virion. It is reported that there is one nucleoprotein for every six nucleotides in the
4

genome and that this interaction is very strong and stable(15, 16). This complex of viral
RNA coated in nucleoprotein is known as the viral nucleoprotein or vRNP. 2) The
phosphoprotein (P) is a cofactor for the viral polymerase and is required for viral
replication and efficient nucleocapsid formation(17, 18). 3) The Matrix protein (M) lines
the inner membrane of the virion and is important for driving contact between the vRNP
and the surface proteins(19, 20). 4+5) The surface proteins are Fusion (F) and
Hemagglutinin (H) proteins (or Glycoprotein (G) or Hemagglutinin/Neuraminidase (HN),
depending on functionality), and are responsible for cell fusion and cellular attachment
and activation of fusion respectively(20-22). 6) The polymerase or Large protein (L) is
the RNA dependent RNA polymerase (RdRP) that catalyzes the addition of nucleotides
and includes methyltransferase activity for capping nascent mRNA(14, 23).
Paramyxoviruses also encode a number of accessory proteins from the P gene, the
number and type of which vary by genus, that primarily function as innate immune
antagonists(24).
Paramyxoviruses enter the cell by fusion at the plasma membrane.
Hemagglutinin proteins bind to cell surface receptors and trigger conformational changes
to allow the fusion protein to direct fusion between the viral membrane and the cellular
plasma membrane(25) whereby viral genomic contents are deposited into the host
cell(26). Upon entry, negative sense viral genomes are coated with nucleoprotein and
carry with them L and P proteins. The L-P protein complex, or polymerase complex,
recognizes the leader sequence at the 3’ end of the virus and synthesizes short RNA
strands before recognizing a gene start signal, which signals for the polymerase to
create a capped mRNA. The polymerase continues to synthesize mRNA until it reaches
the gene end sequence, where it will stutter along a polyU track to generate a polyA tail
5

for the mRNA. The polymerase then continues to scan the viral genome until it finds the
next gene start sequence and begins to make the following mRNA(14). As the
polymerase continues along the viral genome, it may lose processivity and fall off of the
template strand. This leads to a gradient of mRNA expression where the first
synthesized (3’ proximal) mRNAs are in highest abundance and the last synthesized (5’
proximal) mRNAs are at the lowest abundance(27) (Fig. 1.1.A). Viral mRNA is then
translated and post-translationally modified by host cell ribosomes and host proteins.
After several rounds of transcription and the accumulation of viral proteins, the
viral RdRP will change from “transcriptase” mode to a “replicase” mode and instead of
synthesizing mRNA will begin to synthesize viral RNA (vRNA) genomes. It is
hypothesized that the switch between transcriptase and replicase is governed by
accumulation of NP proteins, whereby when a sufficient level of NP proteins coat the
nascent RNA generated from the 3’ end of the leader, the RdRP will bypass gene start
events to create a vRNA(28, 29). The processive synthesis of vRNA form the negative
strand genome yields a positive sense anti-genome, which is also completely coated in
NP. The positive sense anti-genome contains the inverse trailer region which acts as a
promoter and can be recognized by the RdRP to initiate replication. Importantly, the
trailer region does not initiate any transcription events, and only replication can occur
from this promoter. The antigenome is used as a template to generate negative sense
genomes, which are able to propagate the viral lifecycle(14, 30). It has been reported
that in Sendai virus, the trailer region is about 40 times stronger a promoter than the
leader region which drives the synthesis of higher levels of negatives sense genomes
during infection(29, 31) (Fig. 1.1.B).

6

Figure 1.1 General Replication Strategy of Paramyxoviruses (A) Gene organization of SeV
(B) Replication strategy of paramyxoviruses (1) Upon entry, the viral polymerase synthesizes
capped and polyadenelyated mRNA, beginning at the 3’ end of the genome. The polymerase
progressively loses processivity leading to a gradient of mRNA with high levels of 3’ proximal
mRNAs and low levels of 5’ proximal mRNAs. (2) After initial transcription of viral mRNA and
accumulation of viral proteins, the polymerase switches to replication and generates an
antigenome that is coated with nucleoprotein as it is synthesized (3) Positive-sense anti-genomes
coated in nucleoproteins are replicated by the polymerase beginning at the 3’trailer to generate
more negative-sense genomes.

1.1.2.2 Intracellular sites of replication
In contrast to positive sense RNA viruses which form membranous vesicles or
associate with the endoplasmic reticulum, paramyxoviruses replicate within the
cytoplasm of infected cells. Additionally while the nucleocapsid and matrix proteins of
some paramyxoviruses have been reported to transit through the nucleus for post
translational modifications such as ubiquitination(32, 33), their genomes do not have a
nuclear phase. Viral genomes are replicated freely in the cytoplasm of cells. While
inclusion body (IB) formation appears to be a hallmark of other negative sense virus
families, including rhabdoviruses(34), filoviruses(35), and pneumoviruses(36, 37), some
but not all paramyxoviruses have been reported to form inclusion bodies during
7

replication. For example, formation of inclusion bodies is a hallmark of Canine distemper
virus (CDV)infection(38). Additionally, while IBs have been described to form during
infection with parainfluenza virus 5 (PIV5)(39), measles virus(40, 41), and NiV(42), these
IBs have been characterized as dynamic, forming and diffusing during infection. IBs are
protein condensates that form in the cytoplasm and are driven by the accumulation of
viral proteins with intrinsically disordered domains. These IBs are often classified as
membranelles organelles that form by liquid-liquid condensation(37, 43). IBs are thought
to concentrate viral RNA and viral proteins within the cytoplasm to increase rates of
replication and to shield viral RNA from host cell sensors(44). However, not all
paramyxoviruses replicate using IBs and the factors that dictate the formation of these
inclusion bodies is not well understood.
1.1.3 Paramyxovirus Assembly and Virion Components
While viral genomes are replicated in the cytoplasm of infected cells, the virus
buds from the plasma membrane and therefore the genome must be trafficked to the
plasma membrane for virion assembly(20). Many negative sense RNA viruses have
developed strategies to target their genome to the plasma membrane by hijacking the
host recycling endosomal pathway(45). Host recycling endosomes travel along actin and
microtubules propelled by the small guanine triphosphatase (GTPase) Rab11a.
Recycling endosomal networks transport cargo in a bidirectional manner, to and from the
perinuclear endosomal recycling center and the plasma membrane(46). This concerted
bidirectional movement has been coopted by a number of viruses including
paramyxoviruses(47-50), orthomyxoviruses(51, 52), pneumoviruses(53), filoviruses(54),
and hantaviruses(55).
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The paramyxoviruses Sendai virus(48), measles(50), mumps(49), and human
parainfluenza 1 virus(47) have been shown to be dependent on Rab11a and
microtubules for the movement of vRNPs within the cytoplasm and for the production of
infectious particles (Fig. 1.2). Whereas vRNPs use Rab11a to traffic to the plasma
membrane, the surface proteins F
and HN are synthesized in the
endoplasmic reticulum and
trafficked to the plasma membrane
via the secretory pathway (22) and
are preferentially sorted to lipid
rafts(56). F and HN are thought to
be trafficked independently of each
other and recent work has shown
that NiV surface proteins are
stochastically incorporated into
virions, rather than being
incorporated at a fixed
stoichiometric ratio, supporting the
idea that these proteins reach the
plasma membrane independently

Figure 1.2. Schematic of Paramyxovirus Assembly
Viral ribonucleoprotein complexes are replicated in the
host cell cytoplasm. After accumulation of viral
proteins, vRNPs use recycling endosomes to transit to
the plasma membrane where they interact with matrix,
Fusion and hemagglutinin/neuraminidase proteins
distributed on the cell surface.

of each other.
The oligomeric matrix protein which forms a matrix along the plasma membrane
serves to bridge the contacts between the surface proteins and the vRNPs(19). The
incorporation of NiV F and G protein into virion occurs by interactions with matrix
9

protein(57). Matrix is also thought to direct specificity of vRNP incorporation into virions.
For example, while NP proteins from closely related SeV and HPIV1 are able to coat the
others genomes, they are not able to interact with their orthologous matrix protein and
form viral particles, indicating that NP-matrix contacts are important for producing
virions(58).
While the expression of matrix protein alone is sufficient to drive the production of
virus like particles in cells for most paramyxoviruses, including SeV(59) and HPIV1(60),
the association between the vRNPs and matrix is thought to enhance budding as vRNPs
induce curvature of the host membrane to induce scission(61). While many viruses
including retroviruses, filovirus, and rhabdoviruses use ESCRT proteins to drive
membrane scission and produce particles, the use of ESCRT by paramyxoviruses is not
universal(62). Viruses that use ESCRT for particle production include NiV(63), PIV5 (64)
and mumps(65). These viruses recruit ESCRT proteins via PPXY-like late domains in
their matrix proteins. However, other paramyxoviruses including measles bud in an
ESCRT independent manner(66). In addition, other membrane scission proteins
involved in vesicle formation such as Aip1/Alix have been shown to be recruited by
matrix and C proteins to enhance particle production in SeV(67, 68), but their
requirement for particle production remains contested(69). The accessory protein C,
generated from the P gene mRNA in SeV, HPIV1, MeV, NiV and others, has also been
implicated to play a role in particle production, either by enhancing the recruitment of
Aip1/Alix or Tsg101, an ESCRT component, to the plasma membrane(63, 68) or by
driving vRNP migration to the plasma membrane(70).
Though particle production has been long studied and the identification of the
involvement of Rab11 endosomal pathway has illuminated mechanisms of virus
10

trafficking to the plasma membrane, there are still a number of questions surrounding
the assembly of paramyxoviruses. First, the viral and host proteins that are critical for
vRNP interaction with Rab11a are unknown. It is clear that vRNPs interact with Rab11a,
but, the elements of the vRNP that interact with Rab11a are unknown. In addition, it
remains to be determined if another viral protein or other host factors are involved in this
interaction. Further, the mechanisms of transport of matrix proteins and the involvement
of C protein in particle production remain contested despite having been studied for a
long time. Finally, differences amongst paramyxoviruses, particularly in those that
express different accessory proteins, remains to be explored. The identification of
specific mechanisms of either virus or host proteins involved in virion assembly could
provide targets for the development of antivirals for a number of important diseases.
1.1.4 Sendai Virus
Sendai virus (SeV), recently renamed murine parainfluenza virus 1, is a member
of the respirovirus genus of the paramyxovirus family. The SeV genome is approximately
15kb in length with enveloped virions ranging in size from 110-540nm in diameter, based
on the amount of viral RNA that has been packaged(71). As a prototypical
paramyxovirus, SeV expresses the six common genes, as well as a large number of
accessory proteins from the P gene. These accessory proteins include four C proteins
(C, C’, Y1, and Y2), which have been described to antagonize the interferon response by
binding to STAT1 and preventing its nuclear translocation(72), as well as having roles in
particle production as discussed above(70), and regulating the polarity of genome
synthesis(73). C proteins are generated from the P mRNA by translation initiations at
alternate start sites downstream of the primary AUG(74). V proteins are expressed from
mRNA generated by the insertion of a G during P mRNA synthesis which creates a
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frame shift. Therefore V proteins share N terminus amino acid sequences with P but
have a unique C terminus. The V protein is an innate immune antagonists and functions
by blocking MDA5 activation to prevent IRF3 activation(75), blocking NLRP3
inflammasome activation to prevent IL1b secretion(76), and binding to RIG-I/TRIM25 to
prevent RIGI ubiquitination and subsequent activation(77). These proteins are
dispensable for replication in vitro but are required for pathogenesis in animal
models(78, 79).
SeV infects rodents and causes a respiratory disease, with virus restricted to
replication in the lung in the presence of tryptase Clara, a specific trypsin secreted by
Clara (or Club) cells in the lung(80). While the virus has a strong organ specific tropism,
and primarily replicates in bronchial epithelial cells, type I and type II pneumocytes, and
alveolar macrophages, there are no entry specific factors that restrict this virus to
rodents or to respiratory tissues, as SeV enters via binding to sialic acid(81). In natural
hosts, SeV causes an acute disease and spreads rapidly amongst outbred and wild
animals primarily via contact, with peak virus titers occurring 4 to 5 days post
infection(82). Disease is characterized by roughened coat hair, dyspnea and, weight
loss(1). Viral clearance is dependent on CD8+ T cells that are recruited to the lung by
strong innate immune responses initiated by cell intrinsic immunity(83, 84). Mice will
clear detectable SeV by day 10 or 11 and develop immunity characterized by a robust
CD8+ T cell and antibody response. However, SeV can cause long term damage to
lungs of infected animals(85, 86) and there is long standing evidence that SeV can
remain as a persistent infection and be reactivated throughout the lifetime of
hamsters(87).
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SeV is most closely related to human parainfluenza virus 1, with 69% sequence
homology at the nucleotide level. In fact, their high degree of similarity leads to cross
reactivity of neutralizing antibodies both in humans and mice(88). Other respiroviruses
closely related include HPIV3 and bovine parainfluenza virus. Because SeV can be
easily studied in its natural host, it provides an excellent model system for studying these
important human diseases. Additionally, SeV has been a longstanding model for
paramyxoviruses and for negative sense single stranded RNA viruses as a whole with
which many fundamental discoveries regarding the replication of RNA viruses have been
made.
1.2 Defective Viral Genomes
DVGs exist across many viral families including DNA viruses, retroviruses, and
RNA viruses(89-91). Defective viral genomes (DVGs) are viral replication products
derived from the parental genome that in the absence of coinfection with a standard
virus are unable to carry out a full replication cycle. DVGs can have small to large
internal substitutions, deletions, and/or insertions that make the genome unable to
produce one or more critical proteins while retaining their replication and packaging
potential. Replication strategies of viruses are diverse, and the species of DVGs
generated during replication are just as diverse within and across viral families.
However, DVGs may be produced whenever a virus replicates.
1.2.1 Types and Generation of defective viral genomes
Among RNA viruses there are two dominant types of DVGs: deletion DVGs and
snapback or copy-back DVGs. Both types of DVGs maintain the ability to complete a full
replication cycle when complemented by a standard virus.
1.2.1.1 Deletion Defective Viral Genomes
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Deletion DVGs retain both genomic termini that contain replication promoters but
lack internal regions of the viral genome (Figure 1.3). Deletions can range from a few
nucleotides, leading to alterations in or loss of certain

Figure 1.3. Types of DVGs and their proposed mechanisms of generation. Deletion
DVGs are generated when the polymerase falls off a template strand at a break region and
either switches to a new template strand or continues along the same template strand while
skipping internal regions, rejoining at a deletion rejoin region that may have sequence
homology to the region immediately following the break point. Copy-back DVGs are generated
when the polymerase releases the template strand at a break point and rejoins the nascent
strand at a nonhomologous region, creating a nonhomologous theoretical loop structure
flanked by complementary ends. Snapback DVGs are formed similarly to copy-back DVGs but
lack significant nonhomologous regions because the rejoin points are proximal to the break
points. Abbreviation: DVG, defective viral genome. Figure published in (92).

viral proteins, to large truncations that preserve only the minimum amount of genome
required to undergo replication by the viral polymerase(93, 94). Deletion DVGs are often
found in positive-sense RNA viruses, including flaviviruses(95), alphaviruses(96),
coronaviruses(97), and picornaviruses(98). Deletion DVGs are hypothesized to be
formed when the viral polymerase begins to copy the template strand but falls off from
the template at a break point and continues replication at a distal rejoin point on a new
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template, skipping internal regions of the genome. Identification of small degrees of
sequence homology at the break and rejoin regions of deletion DVGs led to the
hypothesis that DVG generation may be driven by homologous recombination(96, 99).
This hypothesis is supported by evidence that mutations in the viral polymerase that
enhance recombination lead to more DVG generation in alphaviruses(96). Additionally,
analysis of poliovirus DVGs indicated that predicted secondary structures in the genome
encourage copy-choice recombination around sites frequently found in DVGs(100).
The majority of DVGs described from the negative-sense RNA influenza viruses
and bunyaviruses are also deletion-type DVGs(101-103). Like in positive-strand RNA
viruses, sequences in the break and rejoin regions of influenza virus DVGs share
nucleotide similarities(104, 105). However, unlike in positive-strand viruses, homologous
recombination events are rare in negative-strand viruses including influenza(106).
Mutations in the influenza virus polymerase acidic (PA) protein enhance DVG
generation(107, 108), and it has been hypothesized that tertiary structures of influenza
viral ribonucleoproteins may underlie the relationship between break and rejoin
points(105), indicating that DVG generation in these viruses may be driven by different
mechanisms.
1.2.1.2 Copy-Back and Snapback Defective Viral Genomes
The predominant species of DVGs found in negative-sense RNA viruses are
copy-back and snapback genomes. These DVGs are generated from the 5′ end of the
viral genome and consist of a theoretical loop with complementary ends(109) (Figure
1.3). Snapback DVGs, differently from copy-back DVGs, do not contain much of a loop
and are predominantly complementary with as little as a single noncomplementary
nucleotide (110). Mechanisms for the generation of this type of DVG are still poorly
understood. The prevailing model is that during viral replication the polymerase falls off
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the template strand at a break point, rejoins the nascent strand at a rejoin point, and
begins to copy back. Unlike minimally complementary regions found in break and rejoin
points in deletion DVGs, there does not seem to be homology between break and rejoin
points in copy-back DVGs. Because of the lack of a discernable pattern of copy-back
DVG generation, it was thought to be a random process driven by an error-prone viral
polymerase. However, sequence analysis of DVGs from the rhabdovirus vesicular
stomatitis virus (VSV) found that some sequences may act as signals to the polymerase
and may be more prone to act as break or rejoin points(111). Additional work from our
laboratory shows that there are conserved regions in the genome of the pneumovirus
respiratory syncytial virus (RSV) that act as rejoin points during infection and that a
specific nucleotide composition is required in these regions for optimal DVG formation
(112). The molecular mechanisms underlying the use of these specified break and rejoin
points are the subject of current investigation.
1.2.1.3 Other Types of Defective Viral Genomes
While deletion and copy-back DVGs are the most prevalent, a wide range of viral
genomic products can be classified as DVGs. A recently described type of DVG in
influenza virus does not contain any deletions; rather, a viral segment is heavily mutated
in promoter regions and packaging signals so that it interferes with replication of the
standard virus(113). Other types of DVGs include mosaic or complex DVGs, which
include viral genomes from different segments of segmented viruses, different viruses
coinfecting a single host cell, or parts of the host genome(105, 114).
1.2.2 Defective Particles and Their Defective Viral Genomes
It is important to make the distinction between DVGs and defective particles
(DPs) (historically referred to as DIPs) when interpreting literature and considering the
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effects that defective viruses have during an infection. DVGs are, as described, viral
genomes lacking regions of the genome that render them replication incompetent in the
absence of a standard virus. These genomes may be either inside cells or inside viral
particles. DPs are virions that contain a DVG. DIPs, as historically referred to,
necessitate the function of interference, as is stated in their name; however, not all DPs
are necessarily interfering.
DVGs may be generated de novo within an infected cell by the mechanisms
discussed above. While specific conditions that facilitate either the generation or the
accumulation of DVGs are unknown, there is evidence that host factors including host
species and cell type can influence DVG generation. For example, avian influenza virus
strains are more likely to generate aberrant replication products when they replicate in
mammalian hosts and vice versa(115, 116), and West Nile virus (WNV) DVG generation
and accumulation are affected by the host cell type and mouse strain used to expand the
virus(117). Additionally, viral factors are implicated in DVG generation. Various
mutations in the polymerase that alter fidelity can encourage DVG generation(96, 107),
and different viral accessory proteins are implicated in regulating DVG generation in
paramyxoviruses and orthomyxoviruses(118-120). Regardless, DVGs are generated
when infections occur at a high multiplicity of infection(109, 121). DVGs generated de
novo within an infected cell may impact the rate of standard virus replication and the
accumulation of viral proteins, and they may have different functional consequences
within the cell (Fig. 1.4).
DPs can spread to other cells during infection. To create a DP, a DVG must be
packaged into a virion, and for some viruses this process requires a specific packaging
signal. If deletion DVGs fail to retain packaging signals, they will not be transmitted as
DPs. Examples include deletion DVGs generated during Semliki Forest virus, which
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Figure 1.4 Impact of DVGs during infection. DVGs can limit standard viral replication
through interference in a number of different ways within an infected cell, often with one type of
interference leading to multiple levels of restriction on the standard virus. (1) DVGs can
compete with standard virus for viral replication machinery including polymerase and
nucleoproteins and may be at an advantage to standard virus due to their size or their
promoters, leading to a decreased ratio of standard virus to DVGs. (2) Increased levels of
DVGs compared to standard virus can decrease available templates for viral mRNA synthesis
either because deletion DVGs lack coding regions for certain mRNAs or because copy-back
and snapback DVGs are unable to code for any mRNA and thereby lead to reduced
accumulation of viral proteins in the cell. (3) The limited amount of viral proteins can lead
DVGs to compete with standard virus for surface proteins for assembly, compete with standard
segments for incorporation into virions in segmented virus, or even induce degradation of
surface proteins, leading to a decrease in virion production. (4) Increased accumulation of
DVGs within the cell can trigger pattern recognition receptors to initiate signaling cascades
leading to the upregulation of interferons and interferon-stimulated genes, which can in turn
have inhibitory effects on viral replication or particle production. Abbreviations: DVG, defective
viral genome; ISRE, interferon-sensitive response element; PAMP, pathogen-associated
molecular pattern; PRR, pattern recognition receptor. Figure published in (92)

helped define critical packaging signals in the viral nonstructural protein nsp2(122), as
well as clinically isolated DVGs identified in Middle East respiratory syndrome
coronavirus that contain large deletions between ORF5 and the E gene and, therefore,
may be unable to be packaged(123). These types of DVGs may affect the cell in which
they arise de novo but might not be transmitted or amplified in other cells, except
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potentially by mechanisms of virion-free cell-to-cell transmission(124).
For DVGs that can be packaged into virions, not all types of DVGs may be
efficiently packaged and transmitted. Competition assays between the paramyxovirus
Sendai virus (SeV) DVGs of different sizes show that larger DVGs have a packaging
advantage over smaller DVGs, likely because they are better at inducing the membrane
curvature required for particle formation(61, 125). However, these findings do not
exclude the possibility that high levels of replication of smaller DVGs interfere with virion
production in other ways. Similarly, different alphavirus DVGs are more or less efficiently
packaged into DPs when propagated or produced in different cell lines(122).
Furthermore, DVGs may have additional requirements for budding, as is the case for
lymphocytic choriomeningitis virus (LCMV) DVGs. The PPXY domain of the matrix
protein, Z, can be reversibly phosphorylated, and this posttranslational modification can
either enhance or restrict production of DPs depending on which residue is
phosphorylated, indicating a potential mechanism for the virus to regulate DP
generation. Interestingly, production of LCMV DPs relies on the endosomal sorting
complex required for transport (ESCRT) pathway, whereas standard virus particles can
be produced in the absence of ESCRT and do not require the PPXY domain(126, 127).
1.2.3 Defective viral genomes and Disease
1.2.3.1. Defective Particles and Disease Outcome
Many early studies of the role of DVGs during infection were performed in the
context of DPs. Most notably, the first studies using influenza virus showed that smaller
noninfectious particles could influence the outcome of infection by reducing viral titers
when the virus was grown in cell cultures or in eggs(128-130). After that, DPs for many
other viruses were described including the negative-strand viruses SeV(131) and
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VSV(132) and the positive-strand viruses Semliki Forest virus(133), Sindbis virus(134),
and poliovirus(135).
Work in the 1970s and 1980s showed that DPs influenced infection outcomes in
mice. In infections with Semliki Forest virus(136, 137) or with influenza virus(138, 139),
mice that received an inoculum containing high levels of DPs in addition to the standard
virus were protected from disease and had reduced levels of viral replication and virus
dissemination compared to those receiving standard virus alone. Production of virus
stocks with higher levels of DPs was observed when virus was grown to high titers or
when animals were infected with viruses that contained high levels of DPs during initial
infection. However, because the de novo production of DPs was observed only in
viruses grown to high titers in tissue culture, the presence of DPs in natural infections
was questioned and progress in the field slowed.
Work in the past decade has reexamined the role of DPs in disease outcome,
and the original findings with orthomyxoviruses and alphaviruses have been confirmed
and expanded to a number of additional viral families. Mice infected with stocks of SeV
containing high amounts of DPs were protected from weight loss early during infection
and induced stronger immune responses compared to mice infected with virus
containing low amounts of DVGs. These findings were replicated by supplementing low
DVG virus stocks with purified DPs, indicating that this protective effect is due to the
addition of DPs(140). Similar observations were obtained in infections with influenza
virus (140) or the pneumovirus RSV(141).
The role of DPs in viral infections was also expanded to arboviruses and
nonvertebrate hosts. Infections of Drosophila with Sindbis virus with a high content of
DVGs survived longer than flies infected with virus with a low content of DVGs(142).
Additionally, mosquitos infected with stocks of WNV that contained high amounts of
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DVGs had reduced infection, viral replication, and dissemination compared to those
infected with stocks with low levels of DVGs. Interestingly, WNV findings in mosquitos
were not recapitulated in mice, indicating that there may be different effects of DVGs or
DPs in different host species(143).
Whether conclusions from infections of animal models using inocula with high
initial levels of DPs apply to human infections is unclear. Models of interhost
transmission describe high bottlenecks for infection where the production of thousands
of virions from a transmitting host can lead to founding virus populations as small as a
single virion in the receiving host(144). It therefore seems unlikely that during
transmission a cell in a naive receiving host would be coinfected with a DP and a
standard virus particle as this would require inoculation with a high DP to standard virus
particle ratio. However, infections of hosts that are immunosuppressed or have
comorbidities may increase sizes of founding populations, thereby increasing the
probability of cells coinfected with a DP and a standard virus particle. However, initial
infections may also occur with virions that have packaged both a DVG and a standard
viral genome inside a single virion(71), or virions may aggregate during infection to
enhance co-transmission, as reported for VSV(145) and poliovirus(146). Additionally, it
is possible that DPs are independently transmitted during infection and that DVGs
remain silent within a cell until that cell becomes infected with a standard virus before
replicating. For paramyxoviruses, defective ribonucleoprotein complexes are stable
within cells, in the absence of replication for up to 96 hours(147, 148). Evidence that
DVGs are transmitted between hosts during natural infection with influenza virus comes
from finding the same DVG RNAs in patients infected with pandemic H1N1 linked by
direct contact(104), although this does not exclude that the same DVGs were present in
patients due to sequences in the viral genome that promote the generation of DVGs at
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specific regions.
1.2.3.2 Defective Viral Genomes and Disease Outcome in Natural Infections
DVGs have been detected in tissues and fluids of humans and animals infected
with influenza(104), dengue(95), hepatitis C(149), hepatitis A(150), WNV(143), or
measles(151). However, due to a generalized belief that DVGs did not play an important
biological role, the literature on this topic was limited to descriptive rather than
mechanistic studies. Recently, DVGs were identified in clinical samples from respiratory
secretions of children infected with RSV, and, importantly, their presence correlated with
stronger innate immune responses in these patients(152). These observations
demonstrated for the first time that naturally occurring DVGs may play an important role
during natural infections. Further, during natural infections with influenza virus, patients
infected with a virus containing a mutation in the polymerase basic 2 subunit of the
polymerase were more likely to accumulate DVGs. Importantly, this variant was found
more often in patients who recovered from the infection compared to those who were
categorized as severely ill(107).
1.2.4 Mechanisms of DVG Impacts on Infection
DVGs and DPs were first discovered for their ability to interfere with standard
virus replication and production. DVGs were first described in influenza virus infection in
the late 1940s by Preben von Magnus and termed von Magnus particles (128, 129).
Upon infection of the same cell as a standard virus, von Magnus particles reduced the
production of standard virus presumably by competing for resources with the parental
virus. Interference has been demonstrated for DVGs and DPs from a number of viruses,
and in many cases an impact on infection outcome has been demonstrated.
1.2.4.1 Mechanisms of interference
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DVGs can exert interfering pressure at multiple levels during the production of
progeny virus (Fig. 1.3). During replication, DVGs can compete for the viral polymerase
as well as consume the nucleocapsid proteins for coating its genome. The small size of
DVGs confers a replication advantage. In addition, in negative-sense RNA viruses the 5′
trailer promoter is approximately 40 times more favorable than the 3′ leader promoter,
and as snapback or copy-back DVGs are flanked by trailer promoters, they are
replicated at an advantage to a leader-trailer–flanked virus(153). Additionally, DVGs may
accumulate mutations in their promoter regions, which can confer advantages over the
standard virus. DVGs may also compete for structural proteins to be packaged into
virions, thereby limiting the number of infectious particles produced. Particularly for
segmented viruses, the packaging of DVGs into particles can limit levels of infectious
particles(154). Additionally, DVGs may lead to degradation or increased turnover of viral
proteins or suppress structural proteins required for assembly, as is the case in SeV,
where the presence of DVGs associated with increased degradation of the viral matrix
protein and decreased surface expression of the hemagglutinin-neuraminidase
protein(155, 156). t
Although the mechanisms of interference have been hypothesized and studied,
we do not know the exact ratios of DPs that are required to completely interfere with
standard virus replication and particle production. Additionally, it is likely that not all
DVGs exhibit similar interfering abilities. For example, multiple types and sizes of DVGs
from VSV can efficiently interfere with some strains of parental virus, while other parental
strains can replicate these DVGs but do not seem to be subject to interference(157).
Interestingly, not all types of DVGs can interfere with replication of standard virus.
Particularly, certain strains of WNV seem to be insensitive to interference by DVGs
(158). DVGs from WNV also show differing abilities to interfere with virus replication in a
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host-dependent manner, with interference occurring in mosquito hosts but not mouse
hosts(117). These differences in interference ability may be due to host intrinsic factors
that limit DVG replication or to changes in viral replication between hosts.
1.2.4.2 Interference and Disease Outcomes
The role of DVGs in modulating outcome of infection can be attributed in part to
the ability of DVGs to interfere with the standard virus and prevent damage to the host
from viral replication. Data from influenza virus suggest that one DP is sufficient to
temper levels of standard virus replication to levels that limit cytopathology, although the
role that interferon induction plays in this system may confound these
interpretations(159). Interference may play a critical role in determining disease outcome
when animals are infected with high levels of DP-containing virus stocks or when DPs
are given therapeutically or prophylactically. For naturally arising DVGs, the role of
interference and how this dictates host outcome are less clear. Although interference
could certainly play a role within an infected cell that generates a de novo DVG, whether
there will be high-enough DPs produced in a naturally infected host is unclear. The
levels of DPs generated in a particular host and the ratio of DPs to infectious particles
within local foci of infection may critically determine if interference occurs at biologically
relevant levels in vivo.
1.2.4.3 Innate Immune Activation
One of the best-characterized functions of DVGs during infection is their ability to
induce innate immune responses, including expression of interferons, interferonstimulated genes, cytokines, and chemokines. The primary descriptions of DVGs as
inducers of antiviral immunity were during infections with negative-sense RNA viruses. In
the absence of DVGs, there was no immune activation, while in the presence of DVGs at
the onset of infection in the form of DPs, or after de novo generation in a natural
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infection, there was strong induction of the antiviral immune response(121, 140, 141,
160-164). In addition, not all cells engage in an immune response during viral infections,
corresponding with the heterogeneous accumulation of DVGs within infected cells(140,
165). In infections with SeV, cells that accumulated high levels of DVGs were the
primary inducers of interferon as measured by interferon regulatory factor 3 nuclear
translocation(166) and antiviral innate immune signatures obtained by transcriptome
analysis of infected cell populations(165).
DVGs are strong inducers of the innate immune response by acting as strong
pathogen-associated molecular patterns (PAMPs) during viral infection. The addition of
purified DPs to SeV or RSV infections promotes the induction of the antiviral immune
responses in an RLR-dependent manner(141, 163). This response is DVG specific, as
addition of increasing amounts of standard virus is not sufficient to induce interferon to
similar levels(140, 163, 164). Additionally, immunoprecipitation of retinoic acid-inducible
gene-I (RIG-I) followed by RNA-seq revealed that most of the ligands bound to RIG-I
correspond to segments within the 5′ terminus of the virus, the region from which copyback DVGs are formed(167). Moreover, analysis of the RNA structure of the
predominant SeV DVG, DVG-546, found a molecular motif that enhanced binding of
RIG-I and MDA5 to the RNA(166). DVGs produced from measles have also been shown
to bind to RLRs (168, 169), and similar principles apply to other negative-sense RNA
viruses. While certain well-characterized DVGs have been shown to interact directly with
binding partners during infection, this may not be true for all DVGs. First, not all DVGs
are equally good at inducing immune responses, as studies with SeV have shown that
specifically copy-back DVGs induced innate immune responses compared to deletion
DVGs or truncated DVGs(170). Second, it is unknown whether these principles
described for negative-sense RNA virus DVGs will translate to positive-sense RNA
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viruses.
The features that make some DVGs such powerful PAMPs have been
investigated. Because DVGs share most, but not all, sequence homology with standard
virus, sequences within the DVG may facilitate RLR binding and activation, presumably
in an RNA-secondary structure dependent manner. Data using the strongly
immunostimulatory SeV Cantell DVG-546 support this argument(166). However, viral
RNA from negative-sense RNA viruses is thought to be coated in nucleoprotein within an
infected cell, as encapsidation is required for replication, thereby preventing RLRs from
accessing the viral RNA. Analysis of measles virus indicated that the lack of
encapsidation is critical for the induction of innate immune response by DVGs(168),
suggesting that non-encapsidated viral RNA may exist in infected cells. Further, it has
been suggested that SeV DVGs are generated by viruses that encode a variant of the
nucleoprotein that binds viral RNA less tightly(171), potentially exposing viral RNA to
pattern recognition receptors. To reconcile the need for encapsidation for replication and
the lack of encapsidation for immune stimulation, a subset of DVGs may be uncoated
and stimulate immunity and another subset may be fully coated and replicate potentially
exerting interfering pressure. Whether this occurs in the same cell or there are certain
cells that contain non-encapsidated DVGs is unknown, but as only a subset of cells
elicits an interferon response upon infection, it may be that only a subset of DVGs is able
to elicit immune responses.
Another explanation for the ability of DVGs to rapidly induce the antiviral immune
response is their ability to interfere with the expression of viral-encoded antagonists.
Lack or low expression of viral-encoded antagonists allow the virus to trigger an immune
response. However, induction of interferon by DVGs during SeV infections occurs before
viral-encoded antagonists accumulate to high levels(163, 164). Additionally, comparison
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between antagonist proteins in different strains of SeV that differ in their interferoninducing abilities showed no difference in ability to antagonize interferon induction in
transfection-based assays, further supporting the claim that absence of viral antagonism
is not responsible for DVG induced immune responses(171).
Interestingly, interferon antagonists of paramyxoviruses have been shown to limit
DVG generation. The accessory protein C found in paramyxoviruses such as measles,
Human parainfluenza viruses type 1 and 3, and SeV antagonizes the innate immune
response by preventing signal transducer and activator of transcription 1 (STAT1)
phosphorylation. The presence of C limits DVG accumulation, as recombinant viruses
that lack expression of these proteins produce very high levels of DVGs even when
passaged at low multiplicity of infection(118, 119). How C proteins act to limit DVG
generation or accumulation is not known, but it may be related to the role that C proteins
play in altering polymerase preferences for RNA templates(31). Unpublished data from
our lab show that cells that accumulate high levels of DVGs during infection have very
low levels of C expression, but whether a lack of C leads to the accumulation of DVGs or
whether the accumulation of DVGs limits expression of C is yet to be determined. In fact,
these two options are not mutually exclusive, and antagonist or accessory proteins and
DVGs may have multiple levels of coregulation.
1.2.5 Defective Viral Genome–Induced Heterogeneity in Infection
During infections with virus stocks containing DPs some cells accumulate high
levels of DVG RNA while others accumulate predominantly full-length virus RNA(165).
The causes of this heterogeneity are not fully understood but it may be related to the
initial input ratio of DPs to standard virions. (Figure 1.5). Additionally, there is
heterogeneity among cells infected with standard virus that go on to produce de novo
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DVGs(172). This type of heterogeneity may also be driven by input virus levels (as
DVGs are more prone to generation under high multiplicity of infection conditions) or by
host intrinsic factors that regulate DVG production.
The heterogeneity in viral nucleic acid accumulation during infection is important
due to the differing functional outcomes of infected cells. In infections with SeV and
RSV, cells that accumulate high levels of DVGs induce a potent immune response
through retinoic acid-inducible gene-I-like receptors (RLRs) signaling and produce

Figure 1.5 DVG and standard virus dynamics during infection progression. (1) Low DVG
infections will eventually lead to the de novo generation of DVGs within a cell, presumably in
cells infected at a high multiplicity of infection or supporting high levels of viral replication. (2)
Once DVGs are generated, they will accumulate and be released from the cell as DPs. DVG
will then propagate in neighboring cells infected with standard virions. (3) Once high levels of
DVGs have accumulated and sufficient DPs have been released, local foci of infection will
become heterogeneous, with cells having low, intermediate, or high levels of DVGs depending
on infection ratios of DPs to standard virions. (4) As DVGs and DPs accumulate, some cells
receiving high levels of DPs will become DVG high and induce the production of interferons
and cytokines but fail to produce virus or DPs. Progression of low DP infections, presumably
upon natural transmission, will occur from stages 1 to 4. Infection with viral stocks containing
high levels of DVGs or during high particle transmission events will progress from 3 to 4.
Therapeutic or prophylactic administration of DPs will likely result uniquely in stage 4.
Abbreviations: DP, defective particle; DVG, defective viral genome. Figure published in (92).
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interferons, interferon-stimulated genes, cytokines, and chemokines(165, 166). The
triggering of RLRs also stimulates the expression of pro-survival tumor necrosis factor
(TNF) family member proteins and protects these cells from TNF-mediated cell death,
while cells that are enriched in full-length virus are killed by TNF released from DVGhigh cells(165). Heterogeneity in induction of immune responses has also been shown
for other viruses, such as influenza, through single-cell RNA sequencing of cellular
mRNA and viral RNA (172, 173).
In addition to heterogeneity of initiation of immune responses, there is also
heterogeneity in the ability of infected cells to produce standard and defective viral
particles. During infections with VSV, virus particle production is variable when single
cells are examined compared to a bulk population(174). When DPs are added at varying
amounts, the heterogeneity in standard virus production increases. Examination of
single cells revealed that cells vary from producing no virus to producing low or high
levels of virus depending on the input ratio of DPs to standard virus(174, 175). Taken in
concert with the idea that these full-length high cells die promptly in infections, while
DVG-high cells survive, these observations raise intriguing questions as to the dynamics
at play within cells with different contents of DVGs during virus persistence and virus
transmission.
1.3 Experimental Questions
The López lab has long used the murine parainfluenza virus, Sendai virus, as a
model to study the impact of defective viral genomes during infection particularly on the
initiation of the immune response and on the outcomes of infection in mouse
models(140, 141, 163-166). In order to study the impact of DVGs on paramyxovirus
infection at an intracellular level, we developed an RNA fluorescence in situ hybridization
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(FISH) approach that enabled us to distinguish full-length from defective viral genome
RNA. This approach allowed for the visualization of DVGs during infection, which had
previously been difficult due to their sequence homology with the standard virus. Using
this technology, we observed that upon infection with SeV viral stocks containing high
levels of defective particles, there is heterogeneity in the accumulation of DVGs amongst
cells, with some cells accumulating high levels of DVGs and some cells accumulating
high levels of full-length virus. These distinct cellular phenotypes were characterized by
RNA-seq and indicated that these cells engage distinct transcriptional profiles with DVGhigh cells having a pro-inflammatory and pro-survival pathway upregulated in contrast to
FL-high cells which had cellular stress and unfolded protein response pathways
upregulated(165).
In addition to distinct transcriptional status and cell fates of these cells, we
observed that the intracellular localization of viral RNAs in these cells was distinct. While
full-length virus high cells have viral RNA that clusters in a perinuclear region, DVG-high
cells display viral RNA diffusely throughout the cytoplasm. This observation led to
several questions that are the driving motivation for this work, including what the
mechanisms of this differential localization are and how does this differential localization
impact the viral lifecycle during infection. We hypothesized that discrete localizations of
viral RNA would impact viral particle production due to differential engagement with
pathways coopted for virion assembly and that this differential engagement with the host
is driven by different levels of accumulation of viral proteins.
In Chapter 2, I will discuss the characterization of the intracellular localizations of
viral genomes in these two distinct cell populations. We asked which host factors viral
genomes engage with in these cellular subsets and found that viral genomes in FL-high
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cells engage with the Rab11a marked recycling endosomes, while viral genomes in
DVG-high cells do not. I will then explore how these differences in localization impact
particle production, as the Rab11a pathway is critical to initial steps in virion assembly.
In Chapter 3, I will take advantage of the heterogeneity in viral engagement with
the host cell to parse replication and particle assembly to identify critical viral proteins
required for engagement with Rab11a. I will examine the role of M and NP proteins as
well as C protein and the viral polymerase L in during SeV infection in order to better
understand which viral proteins are required for interaction with Rab11a.
Overall, this work seeks to understand the impacts of heterogeneous
distributions of DVGs in SeV infections on particle production and infection dynamics
and harness these differences to understand the role of viral proteins during
paramyxovirus assembly.
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CHAPTER 2: Defective viral genomes alter how Sendai virus
interacts with cellular trafficking machinery leading to heterogeneity in
the production of viral particles among infected cells

The contents of this chapter have been published as:
Genoyer E and López CB. 2019. Defective Viral Genomes Alter How Sendai Virus
Interacts with Cellular Trafficking Machinery, Leading to Heterogeneity in the Production
of Viral Particles among Infected Cells. J Virol 93 (4) e01579-18.
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2.1 Abstract
Defective viral genomes (DVGs) generated during RNA virus replication
determine infection outcome by triggering innate immunity, diminishing virulence, and, in
many cases, facilitating the establishment of persistent infections. Despite the critical
role of DVGs during virus-host interactions, the mechanisms regulating production and
propagation of DVGs are poorly understood. Visualization of viral genomes using RNA
fluorescent in situ hybridization revealed a striking difference in the intracellular
localization of DVGs and full-length viral genomes during infections with the
paramyxovirus Sendai. In cells enriched in full-length virus, viral genomes clustered in a
perinuclear region and associated with cellular trafficking machinery, including
microtubules and the GTPase Rab11a. However, in cells enriched in DVGs, defective
genomes distributed diffusely throughout the cytoplasm and failed to interact with this
cellular machinery. Consequently, cells enriched in full-length genomes produced both
DVG and full-length genome-containing viral particles, while DVG-high cells poorly
produced viral particles, yet strongly stimulated antiviral immunity. These findings reveal
the selective production of both standard and DVG-containing particles by a
subpopulation of cells during infection that can be differentiated by the intracellular
localization of DVGs. This study highlights the importance of considering this functional
heterogeneity in analyses of virus-host interactions during infection.
2.2 Significance
Defective viral genomes (DVGs) generated during Sendai virus infections
accumulate in the cytoplasm of some infected cells and stimulate antiviral immunity and
cell survival. DVGs are packaged and released as defective particles and have a
significant impact on infection outcome. This chapter shows that the subpopulation of
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DVG-high cells poorly engages the virus packaging and budding machinery and do not
effectively produce viral particles. In contrast, cells enriched in full-length genomes are
the primary producers of both standard and defective viral particles during infection. This
study demonstrates heterogeneity in the molecular intracellular interactions occurring
within infected cells and highlights distinct functional roles for cells as either initiators of
immunity or as producers and perpetuators of viral particles depending on their content
and intracellular localization of viral genomes.
2.3 Introduction
Defective viral genomes (DVGs) are the primary immunostimulatory molecules
during infection, both in vitro and in vivo, and stimulate a cellular pro-survival program
that facilitates the establishment of persistent infections (140, 164, 165, 176).
Additionally, DVGs occur in natural infections in humans, likely impacting the infection
outcome (107, 141). However, despite their critical role during virus-host interactions, the
mechanisms regulating DVG production and propagation are poorly understood. The
presence of DPs within viral stocks amplified in the laboratory is nearly ubiquitous and
for decades it has been assumed that all infected cells produce DPs upon reaching a
high titer of virus replication (95, 177-183). However, we have reported remarkable
heterogeneity in the accumulation of DVGs within a subset of cells during infection with
the model paramyxovirus Sendai (SeV). This heterogeneity is associated with distinct
functions of the DVG-high cell population, including the induction of antiviral immunity
(140, 164, 166) and the facilitation of viral persistence via the induction of a pro-survival
cellular program (165). In contrast, cells containing low or no DVGs had a negligible
contribution to these processes. This evidence, together with recent evidence of
heterogeneity in both viral replication and particle production of other RNA viruses (172,
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174, 184-186) led us to investigate how DVGs impacted the production of both DPs and
standard viral particles.
Using RNA fluorescent in situ hybridization (FISH) that allows us to distinguish
defective and full-length (FL) viral genomes within infected cells, we discovered that in
addition to heterogeneity in the amount of DVGs among infected cells, viral genomes
localized to different intracellular spaces in DVG-high and FL-high cells. Importantly, this
differential localization critically impacted the ability of viral RNPs to interact with the
cellular machinery used to produce viral particles. As a result, DVG-high cells had a
drastically reduced production of both standard and defective viral particles compared to
FL-high cells. This study reveals two functionally distinct populations during SeV
infection that can be distinguished by the amount and intracellular localization of DVGs.
In addition, together with published evidence of a critical role for DVGs in driving innate
immunity, this study highlights the critical importance of considering the remarkable
division of labor among infected cells in the study of virus-host interactions.
2.4 Results
2.4.1 DVGs alter the intracellular distribution of viral ribonucleoprotein (vRNP) during
infection
To investigate if the presence of DVGs altered the interactions of vRNPs with
cellular components, we first assessed whether DVGs changed the localization of viral
ribonucleoproteins (vRNPs) in infected cells. To do this, we infected cells with stocks of
SeV strain Cantell depleted of DVGs (SeV-LD) at MOI 1.5 TCID50/cell (HAU of 3 per
5x105cells) and supplemented the infections with increasing HAU doses of purified DPs
containing the SeV Cantell DVG-546 (Fig 2.1A-E). Sendai virus Cantell strain naturally
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produces one specific DVG 546 nucleotides in length, making this an ideal system for
identifying DVGs by PCR (140, 170). We measured the levels of DVG-546 in infected
cells by RT-qPCR and found that amount of DVG-546 increased corresponding to
greater doses of DP as expected (Fig 2.1B). Since viral RNA is associated with
nucleoprotein (NP) to form vRNPs (187), visualization of NP protein was used as an
initial proxy for vRNPs. Using a stock of virus with low contents of DVGs (SeV-LD + pDP
HAU 0), we noted that NP accumulates in a perinuclear region of the infected cell.
However, upon addition of increasing doses of DPs during infection, there was a dosedependent increase in cells that display a cytoplasmic and diffuse NP staining with a
corresponding loss of cells that have predominantly perinuclear NP (Fig 2.1A). To
quantify these differences, we assessed the size of the area occupied by NP per
infected cell and determined that NP became more spread out throughout the cell
cytoplasm with increasing amounts of DVG (Fig 2.1C). Importantly, we also used
immunofluorescence to quantify amount of NP within infected cells and determined that
presence of DVGs did not decrease the amount of NP within infected cells when imaged
at a per cell basis (Fig 2.1D). However, the number of cells that were productively
infected decreased significantly with the addition of increasing amounts of DPs (Fig
2.1E), likely explaining the reported reduction in NP production in cell populations
infected in the presence of DVGs (140).
Next, we examined the localization of SeV NP in the presence of DVGs over
time. To do this we infected cells with SeV-LD (Fig 2.1F) or with SeV containing DVGs
at levels similar to SeV-LD + pDP HAU 20 (SeV-HD), and compared NP distribution.
Distinct intracellular distributions were seen starting at 12 h when NP accumulated to
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Figure 2.1. Defective viral genomes alter viral nucleoprotein distribution within infected
cells. (A) A549 cells infected with SeV-LD MOI 1.5 TCID50/cell supplemented with purified DPs at
indicated HAU, for 24 h and stained for SeV NP (grey) and nuclei (blue). Images captured at 40X,
wide field. Images are representative of 3 independent experiments. Scalebar = 100μm. (B) RTqPCR of SeV (+)DVG-546 relative to GAPDH. (C) Percentage of cells per field that are NP+ as
determined by level of fluorescence above background (D) Quantification of SeV NP amount by
fluorescence intensity and (E) distribution of NP by Pixel area within individual cells at 24 h post
infection. Results show sum of 3 independent experiments with >250 individual cells analyzed per
condition. Individual cells are plotted with a line at mean, error bar represents ± SEM **** = p <
0.0001 by Kruskal-Wallis test, with Dunn’s multiple comparisons test. (F) A549 cells infected with
SeV-LD and (G) SeV-HD for indicated time points and stained for SeV NP (grey) and nuclei (blue).
Images captured at 63X, wide field. Images are representative of four independent experiments.
Scalebar = 100μm. (H) RT-qPCR for SeV NP, (+)gSeV and (+)DVG-546 relative to GAPDH. Data is
represented as mean ± SEM of three independent experiments, ** = p< 0.005, * = p<0.05 by twoway ANOVA with significance indicated between viral infections.
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detectable levels. At this time point, in cells infected with SeV-LD, NP began to uniformly
accumulate in a perinuclear region. This distribution was maintained until at least 36 h
post infection (Fig 2.1F). In contrast, SeV-HD infections demonstrated heterogeneity in
the distribution of NP throughout the time points analyzed (Fig 2.1G). As expected for
bulk population analysis, HD infections showed lower levels of FL genomes and SeV NP
mRNA and higher levels of DVGs compared to LD infections (Fig 2.1H), though as
mentioned earlier bulk population analysis may confound the interpretation of these
data, artificially lowering values of SeV NP levels on a per cell basis. These data
demonstrate that the presence of DVGs during infection alter the intracellular distribution
of NP independent of changes on its transcription.
2.4.2 DVGs and full-length genomes localize disparately in infected cells.
Because the addition of DPs to viral infections altered the intracellular localization
of viral NP, we next investigated and differentiated the intracellular distribution of DVGcontaining vRNPs and FL-genome containing vRNPs using RNA fluorescent in situ
hybridization (RNA FISH). Probes targeting the 5’- end of the (+)-sense genome colored
red and probes targeting the 3’- end of the (+)-sense genome pseudo-colored green
were used to distinguish DVGs in green and FL viral genomes as orange (hybridizing
both red and green probes), as we have described (165) (Fig 2.2A). RNA-FISH of cells
infected with SeV-LD or SeV-LD plus increasing amounts of purified DPs confirmed that
FL genomes and DVGs accumulate in different cells and that their intracellular
distribution is distinct (Fig 2.2B). In SeV-LD infections, FL genomes were clustered in a
perinuclear region and addition of DPs resulted in the appearance of DVG-high cells with
DVGs present throughout the cytoplasm. As the amount of DPs added to an infection

38

Figure 2.2. FL genomes accumulate in a perinuclear region while DVGs are distributed
throughout the cytoplasm. (A) Schematic of (+) and (-) sense probe sets binding to SeV
genomes and anti-genomes. For (+) sense FISH: probes targeting the 5’ end of (+) genome are
shown in red, probes targeting the 3’ end of (+) genome are shown in green, interpreted as:
+gSeV (orange), +DVG (green). For (-) sense FISH: probes targeting the 3’ end of (-) genome are
shown in red, probes targeting the 5’ end of (-) genome are shown in green, interpreted as: -gSeV
(orange), -DVG (green). (B) A549 cells infected with SeV-LD MOI 1.5 TCID50/cell supplemented
with purified DPs at indicated HAU for 24 h followed by (+)-sense viral RNA FISH. Images
captured at 40X, wide field. Images are representative of 3 independent experiments, scalebar =
100μm. (C) A549 cells infected with SeV-HD for 24 h then subjected to (+)-sense viral RNA FISH
or (-)-sense viral RNA FISH. 63X wide field, deconvolved, extended focus is shown. Images are
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representative of three independent experiments, scalebar = 100μm.

increased, the number of FL-high cells decreased while the number of DVG-high cells
with cytoplasmically distributed DVGs increased.
Because probes targeting (+)-sense viral RNA may also hybridize to mRNA, a
set of probes targeting the negative sense genome was used to confirm a distinct
distribution of DVGs and FL genomes in the absence of mRNA labeling. Probes
targeting the 3’- end of the (-)-sense genome colored red and probes targeting the 5’end of the (-)-sense genome pseudo-colored green were used to distinguish DVGs in
green and FL viral genomes as orange (hybridizing both red and green probes) (Fig
2.2A). During infection with SeV-HD (+)-strand probes identified a heterogeneous
population of cells, those that accumulate viral genomes in a perinuclear region and
those that accumulate DVGs diffusely in the cytoplasm, similar to what was observed in
infections with SeV-LD plus DPs (Fig 2.2B-C). Infections with SeV-HD generate distinct
subpopulations comprising ~30% DVG-high cells and 30% FL-high cells in A549 cells at
24 h post infection. Similarly, (-)-strand probes identified perinuclear viral genomes and
cytoplasmic DVGs (Fig 2.2C) indicating that the observed disparate distributions apply
to viral genomes regardless of their sense.
2.4.3 DVG cytoplasmic distribution is independent of their size or sequence
In order to address whether the cytoplasmic distribution of DVGs was due to
properties of the viral genomes, we asked whether this distribution was unique to SeV
Cantell DVGs. This virus strain produces a single 546-nt long cbDVG that is strongly
immunostimulatory (164, 166, 170). Other strains of SeV produce cbDVGs of different
lengths and sequence and their immunostimulatory activity vary (140, 170). SeV 52
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produces larger and less immunostimulatory DVGs than SeV Cantell. We generated a
stock of SeV 52 enriched with DVGs (SeV-52-HD) by passaging the parental strain
undiluted in eggs. This stock had

A

Cantell
52
mock LD HD LD HD

two major DVGs, both longer than
DVG-546 and show

1000
500

as two larger amplicons when

B

SeV-52-LD

amplified with a common set of

SeV-52-HD

Hoechst
- gSeV
- DVG

primers (Fig 2.3A). Infections with
SeV-52-HD revealed cytoplasmic
distribution of DVGs similar to SeV
Cantell infections (Fig 2.3B),

Figure 2.3. Different species of SeV DVGs are
cytoplasmically distributed. A549 cells were infected
with indicated virus for 24 h. (A) Agarose gel
electrophoresis of PCR amplification of DVGs using
common primers targeting all copy-back DVGs. (B)
A549 cells infected with SeV- 52-LD or -HD then
subjected to (-) sense-viral RNA FISH. Images
captured at 63X, widefield, deconvolved. Extended
focus is shown. Images are representative of three
independent experiments, scalebar = 50μm.

indicating that the differential
distribution of FL genomes and
DVGs is common to multiple
cbDVG types and independent of
size or sequence.

2.4.4 Cytoplasmic diffusively distributed DVGs RNPs do not interact with the Rab11a /
microtubule intracellular trafficking machinery
vRNPs from paramyxoviruses and orthomyxoviruses interact with Rab11a and
utilize microtubules to facilitate particle production (45). To test whether SeV DVGs and
FL genomes interacted similarly with this intracellular trafficking machinery, we
performed immunofluorescence for SeV NP as a proxy for vRNPs, in conjunction with
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antibodies targeting a variety of cellular organelles and cytoskeletal components in FLhigh cells or DVG-high cells. FL-high cells (shown as cells with perinuclear distributed
NP) showed strong colocalization of vRNP with Rab11a and microtubules. However,
DVG-high cells (cells with cytoplasmically distributed NP) showed almost no
colocalization between SeV NP and Rab11a or microtubules (Fig 2.4). These data
suggest that vRNPs in DVG-high cells do not interact with the host intracellular
trafficking machinery in the same manner as in FL-high cells. Further, cytoplasmically
distributed NP did not colocalize with mitochondria, the cis-golgi, or the endoplasmic

Figure 2.4. SeV NP colocalizes with Rab11a and microtubules in FL-high cells but not in DVG-high
cells. A549 cells were infected with SeV-LD or SeV-HD for 24 h. Cells were fixed and subjected to
immunofluorescence for viral protein SeV NP (red) and Rab11a (recycling endosomes), α-tubulin
(microtubules), Tom-20 (mitochondria), GM130 (cis-Golgi), or Calnexin (endoplasmic reticulum) (all in
green). Images captured at 100X, confocal. Single plane is shown. SeV LD infection was used to capture
FL-high cells and DVG-high cells were captured from a SeV HD infection focusing on fields with cells
containing majority cytoplasmically distributed SeV NP. Scalebar = 50μm. Global Pearson’s
Colocalization quantified by field for 3 independent experiments, >5 fields per experiment, ** = p < 0.005,
**** = p < 0.0001 by student’s t-test.
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reticulum (Fig 2.4) indicating that DVG RNPs are likely not tethered to organelles within
the cytoplasm. To further confirm that DVG RNPs do not interact with Rab11a in DVGhigh cells, we used combined immunofluorescence and RNA-FISH on cells infected with
SeV-HD to identify vRNPs and Rab11a in FL-high and DVG-high cells (Fig 2.5A). For
analysis, cells were binned as DVG-high or FL-high depending on their ratio of 5’-probe
to 3’-probe to the (-)-sense
genome and Global Pearson’s
correlation of colocalization was
assessed for individual cells (Fig
2.5B). Similarly to what was
observed when tracking NP (Fig
2.4), data indicate that within an
infection in the presence of DVGs,
viral genomes in the subpopulation
of FL-high cells containing
perinuclearly localized vRNPs
interact with Rab11a, but in DVGhigh cells with DVG RNPs
distributed throughout the
cytoplasm there is no significant

Figure 2.5. DVG-high cells show less colocalization
with Rab11a than FL-high cells. (A)
Immunofluoresence for Rab11a (magenta) with (-)
sense viral RNA FISH of A549 cells infected with SeVHD for 24 h with Hoechst staining nuclei (blue). Images
captured at 63X, confocal, deconvolved, extended
focus is shown, scalebar = 50μm. Single channel
image of Rab11a (bottom) and RNA FISH (top) with
Hoechst are shown to the right. (B) Global Pearson’s
Colocalization between Rab11a and 5’ end of genome
quantified per cell for 3 independent experiments, 5
fields per experiment. Cells were binned as DVG+ or
FL+ based on ratio of 5’/3’ probe intensity. Individual
cells are plotted with a line at mean, error bar
represents ± SEM, **** = p < 0.0001 by Mann-Whitney
non-parametric U-test.

co-localization of RNPs with
Rab11a.
To next investigate whether the interaction of vRNPs with the
microtubule/Rab11a machinery indicated functional interactions, we first disrupted
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microtubule polymerization and tested if localization of viral genomes changed. To
disrupt microtubules, cells were infected with SeV-HD for 4 h to allow for virus entry and
then treated with the microtubule disrupting drug nocodazole. RNA FISH was performed
24 h post infection to assess viral genome distribution (Fig 2.6A). Nocodazole disrupted
the localization of FL genomes in FL-high cells agreeing with their colocalization with
microtubules, but did not alter the localization of DVGs in DVG-high cells. FL genomes
redistributed to discrete cytoplasmic clusters while DVGs remained diffused throughout
the cytoplasm, indicating that they were not tethered to microtubules. Levels of SeV NP
transcripts (Fig 2.6B) and genomic SeV RNA (Fig 2.6C) did not change upon
nocodazole treatment, confirming that intracellular viral replication was not affected by
the drug; however, DVG replication levels were reduced upon nocodazole treatment (Fig
2.6C), potentially due to nocodazole’s effects on tubulin, which has been shown to
influence SeV genomic and DVG RNA replication (188). Further, when cells depleted of
Rab11a by siRNA knockdown were infected with SeV-HD for 24 h, FL genomes failed to
localize to the perinuclear region and instead distributed throughout the cytoplasm, but
the distribution of DVGs remained the same (Fig 2.6E). Rab11a knockdown was
confirmed by testing for mRNA levels (Fig 2.6F) and protein expression using western
blot (Fig 2.6J). Viral replication was equivalent or increased in knockdown cells, likely
due to impaired particle production and consequent accumulation of viral genomes and
DVGs in the cell (Fig 2.6G-I). As expected, Rab11a knockdown decreased levels of
infectious virus production compared to controls (Fig 2.6K). In order to investigate
whether there was a similar impact on the production of defective particles, supernatant
from control or Rab11a-knockdown infected cells were added to LLCMK2 cells and
levels of intracellular DVGs were measured by RNA. Because Rab11a knockdown
reduced infectious virus production, LLCMK2 infections were adjusted to MOI 1 using
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supplemented SeV LD. Interestingly, DVG-RNA levels in LLCMK2 cells treated with
supernatants from infected Rab11a knockdown cells were reduced compared to cells
treated with supernatants from infected control cells (Fig 2.6L) indicating that production
of defective particles were reduced in the absence Rab11a, while levels of SeV

Figure 2.6. Cytoplasmic distribution of DVGs in DVG-high cells is independent of
microtubule integrity and Rab11a expression. (A) A549 cells infected with SeV-HD, treated
with nocodazole at 4 h post infection, (+) sense viral RNA FISH performed at 24 h post infection.
Images captured at 63X, widefield, deconvolved. Extended focus is shown. Scalebar = 100μm.
Images are representative of four independent experiments. RT-qPCR for (B) SeV NP, (C)
(+)gSeV and (D) (+)DVG-546 transcripts relative to GAPDH at 24 h post infection. Data is
represented as mean ± SEM of three independent experiments, * = p < 0.05 by paired t-test. (C)
A549 cells transfected with siRNA targeting Rab11a or scrambled control siRNA (siCtrl) prior to
infection, infected with SeV-HD for 24 h, then subjected to (+) sense viral RNA FISH. Images
captured at 63X, widefield, deconvolved. Extended focus is shown. Scalebar = 100μm. Images
are representative of four independent experiments. RT-qPCR for (F) Rab11a, (G) SeV NP (H)
(+)gSeV, and (I) (+)DVG-546 transcripts relative to GAPDH at 24 h post infection, data is
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represented as mean ± SEM of seven independent experiments, * = p < 0.05, ** = p < 0.005 by
paired t-test. (J) Western blot for Rab11a protein with GAPDH loading control. (K) Relative levels
of infectious virus by TCID50 normalized to siRNA control, data is represented as mean ± SEM of
three independent experiments, * = p < 0.05 by paired t-test. Supernatant from control siRNA and
Rab11a siRNA KD cells was adjusted to MOI 1 TCID50/cell with SeV LD and LLCMK2 cells were
infected for 24 h. RT-qPCR for Cantell specific DVG-546 (L), (+)gSeV (M) and SeV NP (N)
mRNA relative to GAPDH, data is represented as mean ± SEM of three independent experiments
normalized to SeV LD alone. ** = p <0.005 by One-way ANOVA, Bonferroni post-hoc.

transcription and genomic SeV RNA were the same across infections (Fig 2.6M-N).
Taken together, these results indicate that within an infection, vRNPs in FL-high cells
interact with cellular trafficking machinery involved in virus packaging and budding, while
RNPs in DVG-high cells are localized differently than in FL-high cells and fail to interact
with the cellular machinery used for paramyxovirus budding and particle production.
2.4.5 Virions containing FL genomes or DVGs are produced by FL-high cells and not by
DVG-high cells
Because of the documented importance of Rab11a/microtubule trafficking
pathways for paramyxovirus particle production (45), we next asked if DVG-high cells
produced defective viral genome containing particles (DPs). Taking into consideration
the heterogeneity in viral genomic content among cells infected with SeV-HD (165) (Fig
2.2) we live sorted DVG-high and FL-high cells to obtain enriched populations. To do
this, we took advantage of previous data from our laboratory that identified a subset of
TNF-associated genes that are upregulated in DVG-high cells, including the cell surface
molecule 4-1BB (165). In addition, the SeV HN protein is a surface protein whose
content in infected cells surface is lower in DVG-high cells than FL-high cells (156).
Notably however, even cells with lower levels of HN (HN-low gate) are sufficient to
produce viral particles as sorted SeV-LD infected cells produce similar amounts of
infectious particles from both gates (Fig 2.7A-B). To study viral particle production,
experiments were performed in LLCMK2 cells, which more robustly produce virus
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compared to A549 cells. LLCMK2
cells were infected with SeV-HD,
stained and gated based on their
expression of 4-1BB and SeV HN
for sorting (Fig 2.7C). Sorted
populations were characterized by
RNA FISH (Fig 2.7D) and
compared to unsorted population
controls (Fig 2.7E) and relative
genomic content was confirmed
by RT-qPCR (Fig 2.7F). Sorted
Figure 2.7. Infectious virus is produced by FL-virus
high cells and not by DVG-high cells. (A)
Representative flow cytometry plot of SeV LD infected
LLCMK2 cells, 24 h post infection. HN-low shown in
green, HN-high gate shown in red. (B) TCID50/25ul of
supernatant from indicated cell populations. (C)
Representative flow cytometry plot of SeV HD infected
LLCMK2 cells, 24 h post infection. DVG-high gate
shown in green, FL-high gate shown in red. (D) cytospin
of indicated populations post-sorting and (E) unsorted
SeV HD infected LLCMK2 cells as control subjected to
(+) sense RNA FISH, widefield, 20X. (F) Relative ratio
of DVG to genome calculated by RT-qPCR for DVG546 and +-sense genome in each population, relative to
GAPDH, n = 4, Mann-Whitney non-parametric U-test, *
= p<0.05. (G) TCID50/25ul of supernatant from indicated
cell populations, n = 3, student’s t-test, ** = p<0.005.

cell populations were cultured for
24 h before analyzing their
supernatant for presence of
infectious virus and DPs. As
expected, infectious virus was
predominantly found in the
supernatant of FL-high cells (Fig
2.7G). Because low levels of DPs

are not detectable by titration nor by hemagglutination, the content of DPs was assessed
after amplification in LLCMK2 cells. To do this, LLCMK2 cells were infected with a
combination of SeV-52-LD and supernatants from the cultured sorted populations. To
confirm that SeV-52-LD was able to support replication of SeV Cantell DVG-546, purified
DPs (HAU 20) were added to SeV-52-LD MOI 1.5 TCID50 infections and levels of DVG546 (Fig 2.8A) and genomic SeV (Fig 2.8B) were analyzed and showed an increase
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over time. Upon infection of
LLCMK2 with sorted cell
supernatants, intracellular levels
of SeV Cantell-specific DVG-546
were analyzed 24 h post infection
by RT-qPCR. Interestingly,
despite the abundance of
intracellular DVGs, supernatant
from purified DVG-high cells did
not contain DVG-546 DPs, as
there was no difference in the
levels of DVGs in SeV-52-LD plus
DVG supernatant compared to
Figure 2.8. Defective particles are produced by FLvirus high cells and not by DVG-high cells. Purified
defective particles added to SeV-52 and levels of (A)
(+)DVG=546 and (B) (+)gSeV were measured at 6 and
24 h post infection. Three independent experiments are
shown, * = p<0.05, *** = p < 0.001, by two-way ANOVA
Sidak’s multiple comparisons. Supernatant from sorted
cells was mixed with SeV 52 at MOI 1.5 TCID50/cell and
LLCMK2 cells were infected for 24 h. RT-qPCR for (C)
Cantell specific DVG-546, (D) (+)gSeV, (E) IFNB, and
(F) IFIT1 mRNA relative to GAPDH, n = 3, one-way
ANOVA, Bonferroni post-hoc, ** = p <0.005.

SeV-52-LD alone. Rather, DVG546 DPs were present in the
supernatant from purified FL-high
infected cells (Fig 2.8C), however
there was no difference in levels
of genomic SeV RNA (Fig 2.8D).
Because we chose to amplify the

supernatants in LLCMK2 cells to see robust virus replication, levels of IFNB and IFIT1
are lower than in A549, as LLCMK2 cells are rather poor inducers of interferon.
However, as expected, the presence of DPs correlated with increased expression of
IFNB and IFIT1 mRNA (Fig 2.8E-F) compared to mock levels. Together with published
evidence of a critical role for DVG-high cells in engaging the antiviral response, these
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data demonstrate the distinct functional properties of different cells during viral infections
and identify viral particle production as a distinctive function of FL-high cells.
2.4.6 DVG cytoplasmic distribution is independent of antiviral signaling and cell type
DVGs from SeV Cantell strongly stimulate the RIG-I-like-receptor (RLR) pathway
and induce the expression of type I and III IFNs and hundreds of interferon stimulated
genes (164, 166, 167, 170). Agreeing with the well-known immunostimulatory activity of
DVGs (90), SeV-HD infections showed robust induction of antiviral responses compared
to SeV-LD infections, including high levels of expression of IFNB and the interferon
stimulated gene IFIT1 (Fig 2.9A-B). To assess if these host responses impacted the
differential distribution of FL genomes and DVGs and consequent different DP
production levels (Fig 2.8), we used CRISPR knockout cell lines lacking the RLR
signaling adaptor mitochondria antiviral signaling protein (MAVS KO), or lacking the type
I IFN receptor (IFNAR KO). Intracellular distribution of FL-genomes and DVGs in
knockout cell lines was similar to their distribution in control cells at 24 h post SeV
infection (Fig 2.9C-E) indicating that cytoplasmic distribution of DVGs in DVG-high cells
is independent of both RLR and IFN signaling. To investigate whether DVG distribution
was dependent on other host factors, we tested a variety of cell lines from various host
species. Infection of SeV in various adherent epithelial non-human cell lines, including
monkey LLCMK2 cells, which support robust replication of virus and are traditionally
used for virus growth and titration, Marine Darby Canine Kidney (MDCK), and Vero cell
lines recapitulated the phenotype seen in A549 cells (Fig 2.7E and data not shown). The
independence on anti-viral signaling and host cell type indicate that the intracellular
distribution of vRNPs in FL-high and DVG-high cells is likely virally driven process, the
specifics of it are the subject of current investigations.
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Figure 2.9. Differential distribution of viral genomes is independent of antiviral signaling.
(A) RT-qPCR for IFNB and IFIT1 (B) mRNA relative to GAPDH, n = 3, one-way ANOVA,
Bonferroni post-hoc, ** = p <0.005. (C) CRISPR control A549, (D) MAVS KO, and (E) IFNAR KO
cell lines were infected with SeV-HD for 24 h then subjected to (+)-sense viral RNA FISH. Images
captured at 63X, widefield, deconvolved. Extended focus is shown. Images are representative of
three independent experiments, scalebar = 50μm.

2.5 Discussion
Our data indicate that cells that accumulate high levels of DVGs during an
infection have a distinct cytoplasmic distribution of vRNPs compared to infected cells
that do not accumulate high levels of DVGs, and these RNPs do not engage with the
host cell to produce virions or DVG-containing defective particles (DPs). In contrast, FLgenome and DVG vRNPs in infected cells with low or no DVGs are efficiently packaged
and released as standard virus or DPs. The differential interaction of virus and host
proteins amongst infected cells in a population highlights the complexity and
heterogeneity of viral infections. Most studies of the interactions of host proteins with
viral components have relied on the purification or tagging of viral proteins or viral RNPs.
However, we show that not all vRNPs across different cells within an infected population
behave similarly, as DVG-high cells show differential distributions of viral components
with distinct functional outcomes. The presence of DVGs within prepared viral stocks or
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the accumulation of DVGs during an infection is near ubiquitous for viruses of the order
Mononegavirales, orthomyxoviruses, and others (90, 91). Our results indicate that not
only may DVGs shape the outcome of infection, but also the interaction of viral genomes
with the intracellular trafficking machinery.
DVGs are important modulators of pathogenesis in many, but perhaps not all,
infections as they ameliorate disease courses through the induction of antiviral immunity,
particularly in paramyxovirus infections (140, 141). Additionally, DVG-high cells induce
pro-survival pathways that extend their life span and facilitate the establishment of viral
persistence (165). The differential distribution of DVGs within cells and their failure to
form large perinuclear clusters, may be a clue to some of the functions that DVGs carry
out in driving immunity and stimulating pro-survival pathways. Clustering of viral RNA
into specialized structures in order to evade viral RNA sensing by RLRs has been
described for a number of viruses including those of the paramyxovirus family (44).
Though this specific proviral function has not been described for Sendai virus, the
differential localization of DVGs and their correlation with immune stimulation may offer
an additional explanation for why these viral products so actively engage with RLRs.
A widely described impact of DVGs on virus production is their ability to strongly
interfere with viral protein expression and consequently broadly lower levels of standard
virus replication and virion production (156, 189). However, our data indicate that the
presence of defective particles in an infection led to a reduction in the proportion of cells
able to produce virus rather than a global lowering of virus production in all cells and
indicates the importance of moving away from bulk population analysis when studying
the impact of DVGs on an infection. We show that the presence of high levels of DVGs
within infected cells drastically limits the production of virions by such cell, and the
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mechanisms leading to this reduction in virion production are of interest. Our data
indicates that the immunostimulatory nature of DVGs does not impact these differences
(Fig 2.9), and we presume that interference leading to reduction in certain viral proteins
may play a role. Interestingly, when analyzed on a per cell basis, levels of NP do not
decrease significantly with the accumulation of DVGs within cells, suggesting that not all
viral proteins are subject to stark interference. However, as NP is the first and most
abundantly produced mRNA and protein, there may be additional interfering affects on
subsequent proteins, which may influence viral particle assembly and production. While
DVG-high cells do have decreased levels of HN on the surface, we confirmed that this
level of HN is also found in a subpopulation of DVG-low cells that produces virions at
normal rates. These data suggest that the defect of DVG-high cells in producing DPs
cannot be explained by a reduction in the amount of HN. However, it is possible that
reductions in the amount of other proteins implicated in particle production may play a
role. For example, matrix protein bridges the interactions between viral glycoproteins,
including HN, and vRNPs, yet the details of how it functions in particle assembly are
unknown. Evidence indicates that matrix traffics to the cell surface together with viral
glycoproteins but independently of vRNPs (190) while other evidence suggests that
matrix interacts with cytoplasmic vRNPs and is critical for vRNP transport to the cell
membrane (191, 192). Regardless of how matrix works, high levels of DVGs during
infection can destabilizes matrix leading to failure of virus assembly (155). Whether
matrix interacts with recycling endosomes or facilitates recycling endosome interactions
with vRNPs is unknown. Our data suggest that defects in particle assembly in DVG-high
cells may originate prior to their assembly at the cell membrane, as we fail to see
interaction of DVGs with Rab11a and microtubules required for the trafficking of vRNPs
to the plasma membrane. It is possible that matrix plays an important role in these
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interactions. Analysis of RNA from sorted cells shows that DVG-high cells contain lower
levels of SeV M mRNA transcripts compared to FL-high cells, as expected. However,
they do express SeV M mRNA and it is unclear how these lower levels impact protein
amounts and whether this is a meaningfully lower level of viral protein. Unfortunately,
due to limitations in tools available to study SeV M protein, we are currently unable to
address these questions. Additionally, the non-structural viral protein C has been
implicated in the formation of viral particles through mechanisms that remain
controversial, and C protein is subject to additional regulations at a transcriptional level
which may be altered in DVG-high cells (59, 69, 70). Further investigation into why DVG
high cells fail to engage with these pathways should provide important insight into
mechanisms mediating viral genome trafficking and egress, and possibly reveal
additional roles of matrix or C protein in regulating virion formation.
The production of DPs and the transmission of DVGs during an infection can
have large impacts on the infection outcome in cells (165), in animals (140, 141), and in
humans (107). Here we show that cells accumulating the majority of DVGs during an
infection are not the main producers of DPs. Rather, DPs and virus are produced from
FL-high cells. Notably, FL-high cells die more promptly during infection (165) raising
intriguing questions about the dynamics of virus spread and pathogenesis. The presence
of DVG-high cells during infection occurs in the presence of high levels of DPs, however
during natural infections there may be low levels of transmission of DPs. Therefore, a
natural infection would presumably originally begin as low-DVG. Once DVGs
accumulated in an LD infection (Fig 2.1H), the production of DPs as well as standard
virus could lead to a local area of high-DVG infection and produce DVG-high cells, which
would then be capable of triggering antiviral immunity. The production of DVGs in vivo
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has been established (140) and modeling of DVGs during transmission has been
attempted (174, 193), but we believe that our updated model could yield more insights in
to these infection dynamics. Additionally, the ability to separate and distinguish
defective genomes from FL genomes has allowed us to further characterize properties of
the viral genomes during an infection and reveal that cells enriched in DVGs do not
engage with microtubules/Rab11a-driven viral production pathways. This dichotomy
within a single population is a useful tool not only to understand the immunostimulatory
functions of DVGs in infections, but also allows us to further investigate additional
fundamental aspects of paramyxovirus biology.
2.6 Materials and Methods
Cells and Viruses
A549 cells (human type II pneumocytes, ATCC CCL-185) and LLCMK-2 (monkey kidney
epithelial cells, ATTC CCL-7) were cultured in Tissue Culture Medium (DMEM
(Invitrogen) supplemented with 10% Fetal Bovine Serum (Serum Source International),
Gentamicin (ThermoFisher), Sodium Pyruvate (Invitrogen), L-glutamine (Invitrogen)) at
7% CO2, 37°C. Generation of A549 CRISPR cell lines is described in (8). Cells were
treated with Mycoplasma Removal Agent (MP Biomedical) upon thawing and tested
monthly for mycoplasma contamination using MycoAlert PLUS Mycoplasma testing kit
(Lonza). Sendai Virus was grown in 8-day embryonated, specific pathogen free chicken
eggs (Charles River) for 40 h before allantoic fluid was harvested. LD and HD stocks
were produced as described previously (164). Viruses were characterized by ratio of
TCID50 to direct HA. In brief, TCID50 was determined by 1:10 serial dilutions of virus in
infection media (DMEM (Invitrogen) supplemented with 35% BSA (Sigma-Aldrich),
Pen/Strep (Invitrogen), 5% NaHCO3 (Sigma-Aldrich)) prior to infection of LLCMK2 cells
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for 72 h in the presence of 2 μg/mL TPCK trypsin (Worthington Biochemicals), followed
by hemagglutination of 0.5% chicken red blood cells (Lampire) to determine presence of
virus in the supernatant. Titers were calculated using the Reed and Muench method
(194). Total hemagglutinating (HA) titers were obtained by testing 1:2 serial dilutions of
the virus in PBS for hemagglutination of 0.5% chicken RBCs. TCID50/HA ratios were as
follows: SeV Cantell LD = 195,776; SeV Cantell HD = 48,944; SeV 52 LD = 235,151;
SeV 52 HD = 784. Infections were performed at an MOI of 1.5 TCID50/cell with virus
diluted in infection media. Cells were washed twice with PBS then incubated with
infection media with virus at low volume at 37°C for 1 h. Cells were then supplemented
with 2% FBS Tissue Culture Medium for indicated time periods. Defective Particles (DP)
were purified from the allantoic fluid of SeV Cantell infected embryonated eggs by
density ultracentrifugation on a 5-45% sucrose gradient, as previously described (140).
Immunofluorescence

Cells were seeded on No. 1.5 glass coverslips (Corning) prior to infection. At
indicated time points, coverslips were briefly washed in PBS then fixed in 4%
Paraformaldehyde (Electron Microscopy Sciences) for 10 min. Cells were
permeabilized with 0.2% Triton-X (Sigma-Aldrich) for 10 min. Primary and
secondary antibodies were diluted in 3% FBS/PBS and incubated at RT for 1.5 h
and 1 h, respectively. Nuclei were stained with Hoechst for 10 min prior to
mounting coverslips on slides using Fluoromount-G (ThermoFisher). Antibodies:
SeV NP (clone M73/2 a kind gift from Alan Portner – directly conjugated with
Dylight 594 NHS Ester (ThermoFisher)), Rab11a (Abcam, ab65200), alphatubulin (Abcam, ab52866), GM130 (Abcam, ab52649), calnexin (Abcam,
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ab133615), TOM20 (Santa Cruz, sc-11414), AlexaFluor 647 Phalloidin
(Invitrogen, A22287), Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa
Fluor 488 (Invitrogen, R37116)).
RNA FISH
Custom probe sets (described in Reference (165) and Table 1) conjugated to Quasar
570 and Quasar 670 dyes were purchased from LGC Biosearch. Cells were seeded on
No. 1.5 glass coverslips (Corning) prior to infection. At indicated time points, coverslips
were briefly washed in PBS then fixed in 3.7% formaldehyde (ThermoFisher) for 10 min.
Cells were permeabilized in 70% EtOH for 1 h, washed in wash buffer (2X SSC
(ThermoFisher), 10% formamide (ThermoFisher) in nuclease free water), and then
subjected to hybridization with FISH probes. In brief, probes were diluted to 2.5nM in
hybridization buffer (wash buffer + dextran sulfate) and applied to slides. Slides were
incubated with probe overnight at 37°C in a humidified chamber. Prior to imaging, slides
were washed in wash buffer twice (once with Hoechst to stain nuclei) then 2X SSC.
Cells were mounted in anti-fade buffer (2X SSC, 0.4% glucose (Sigma), Tris-HCL pH 8.0
(USB Corporation) with Catalase (Sigma) and Glucose Oxidase (Sigma)) and sealed
with rubber cement. RNA FISH combined with immunofluorescence includes the
following modifications: after fixation with EtOH, cells are stained with antibody in 1%
BSA (ThermoFisher) PBS with RnaseOUT (Invitrogen); 45 min for 1° Ab, 40 min for 2°
Ab. Cells were then post-fixed for 10 min in 3.7% formaldehyde prior to hybridization.
Microscopy and Image Analysis
Widefield images were acquired on a Leica DM1000 microscope with 40X (1.25-0.75
NA) and 63X (1.40-0.60 NA) oil-immersion objectives. Confocal images were acquired
on a Leica SP5-II Laser Scanning Confocal with 63X (1.40-0.60 NA) and 100X (1.46
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NA) oil-immersion objectives with pixel size of 50.4nm x 50.4nm for immunofluorescence
images and 120.2nm x 120.2 nm for FISH immunofluoresence. Images were
deconvolved using Hugyens Essentials Deconvolution Wizard using theoretical point
spread function and images were processed in Volocity (Perkins-Elmer). Global
Pearson’s Correlation was calculated in Volocity using automatic thresholding based on
(195). For Rab11a/5’(-)SeV colocalization, non-specific nuclear staining was excluded
using the Fiji software by subtracting signal from nuclear area defined by Hoechst
staining. For individual cell measurements ROIs were defined manually for Global
Pearson’s Correlation. Measurements of nucleoprotein distribution and amount were
done using MetaMorph (Molecular Devices) multiwavelength cell scoring application
using phalloidin staining to define cellular boundaries. Single plane images were used
for quantification and plane was determined by phalloidin staining in order to avoid bias.
RNA Extraction and PCR/RT-qPCR
RNA was extracted from Trizol (Invitrogen). Cellular and viral mRNA was reversetranscribed using RNA-to-cDNA kit (Invitrogen). Viral RNA was reverse-transcribed
using SuperScript III First Strand Synthesis System (Invitrogen) with primer 5’GGTGAGGAATCTATACGTTATAC-3’. PCR was performed using Platinum Taq DNA
polymerase (Invitrogen) the reverse transcription primer and 5’ACCAGACAAGAGTTTAAGAGATATGTATT-3’. qPCR was performed with 1:40 dilution
of cDNA, SYBR Green (Life Technologies) and 5uM forward/reverse primers (Invitrogen)
on an Applied Biosystems ViiA 7 Real-Time System. Relative copy numbers per cell
were calculated by delta-delta Ct and normalized to average cellular GAPDH expression
levels. Primer sequences are: SeV NP (F: 5’-TGCCCTGGAAGATGAGTTAG-3’, R: 5’GCCTGTTGGTTTGTGGTAAG-3’), gSeV (F: 5’-GACCAGGAAATAAAGAGTGCA-3’, R:
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5’-CGATGTATTGGCATATAGCGT-3’), DVG-546 (F: 5’TCCAAGACTATCTTTATCTATGTCC -3’, R: 5’-GGTGAGGAATCTATACGTTATAC-3’),
IFNB (F: 5’-GTCAGAGTGGAAATCCTAAG-3’, R: 5’-ACAGCATCTGCTGGTTGAAG-3’),
IFIT1 (F: 5’- GGATTCTGTACAATACACTAGAAACCA-3’, R: 5’CTTTTGGTTACTTTTCCCCTATCC-3’)
siRNA
Cells (3x104) were transfected with 75μM On-TARGET Plus SMARTpool Rab11a
(Dharmacon GE), a mixture of four siRNA targeting Rab11a diluted in Opti-MEM, using
Lipofectamine RNAiMAX (Invitrogen). Transfection was performed 72 h prior to infection
to allow sufficient knockdown. Knockdown was assessed using immunofluorescence,
RT-qPCR, and Western Blot to confirm protein and mRNA levels. Control cells were
transfected with 75μM On-TARGET Plus non-targeting pool following identical
procedures.
Western Blot
Cells were lysed in NP-40 lysis buffer (Amresco) with proteinase inhibitors (Roche
Boehringer Mannheim), Rnase OUT (Invitrogen) and EDTA (ThermoFisher). Protein
concentration was measured using BCA Protein Assay (ThermoFisher). Protein (10μg)
was denatured by boiling for 10 min and loaded in a 10% Bis-Tris Gel (Bio-Rad) then
transferred to PVDF membrane (Millipore). Membranes were incubated overnight with
primary antibody in 5% milk (rabbit anti-Rab11a (Abcam) and mouse anti-GAPDH
(Sigma)). Membrane was incubated with anti-rabbit HRP-conjugated antibody (Cell
Signaling) or anti-mouse HRP-conjugated antibody (Jackson Immunologicals) in 5% milk
and developed using Lumi-light western blot substrate (Roche) to detect HRP.
Drug Treatment
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Four h post infection, media was removed and replaced with 2% FBS tissue culture
media containing 2μg/mL Nocodazole (Sigma-Aldrich) for duration of infection.
Flow Cytometry
Cells were stained with anti-4-1BB (Biolegend clone 4B4-1, #309819) and anti-SeV HN
(Clone 6F11, kindly provided by T. Moran) followed by anti-IgG2a PE-/Cy7 (Biolegend
clone RMG2a-62, #407113) at 24 h post infection. Cells were sorted on BD FACS Aria II
SORP. Mock infected and SeV-LD infected cells were used to inform gating. Analysis
was done using FlowJo_v9.9.4 (BD Biosciences).
Viral Production Analysis
Sorted cells (1.5x105 cells per population) were incubated for 30 min in 1% anti-SeV
mouse serum twice to remove virus bound to the surface. Cells were then seeded in a
24-well plate in Infection Media (described above) and cultured for 24 h. 24 h post
culture, media was collected and analyzed for virus particles. Detection of DPs was
performed by infecting LLCMK2 cells with an inoculum containing 100μl of culture
supernatants with 100ul of infection media containing SeV 52-LD to reach an MOI of 1
TCID50/cell and 2μg/mL TPCK Trypsin (Worthington) for 24 h.
Statistics
Statistics were calculated using GraphPad Prism 5 for Mac.
Table 1. Probe sequences for SeV negative sense genome probes
Probe Sequence

Probe Set/Number

ctcttaaactcttgtctggt

DVG_Negative_1

tggaagtcttggacttatcc

DVG_Negative_2

gtgcagaacgatcgaagctc

DVG_Negative_3
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gctcgtaataattagtccct

DVG_Negative_4

ggtgatatcgagccatatga

DVG_Negative_5

ccgtgattgatgatggatca

DVG_Negative_6

gccaggcaaaatgaatacac

DVG_Negative_7

aggggcagtcaagatgttcg

DVG_Negative_8

taacgtatagattcctcacc

DVG_Negative_9

ttattagacaggtttgagga

DVG_Negative_10

acctgagggttatcacaaaa

DVG_Negative_11

ttatcatcccgtgagatcag

DVG_Negative_12

cctgaccagaagtttgaagc

DVG_Negative_13

tctatgtccacaagattggt

DVG_Negative_14

cttggcagagatatctaggg

negSeV_1

acgattctggaatgcaggtg

negSeV_2

tcaaggatgtggaccttgag

negSeV_3

aagccactgatattgcactt

negSeV_4

gttgaaagatacggcaaccc

negSeV_5

tgctctaagacacgtcatgt

negSeV_6

tgactactctttctgtctca

negSeV_7

tcataggcttcaagtttcgg

negSeV_8

ctatacgagtgtcatgcagt

negSeV_9

tgacagggtatatcctaacc

negSeV_10

taagatcaggtctctgggta

negSeV_11

acatccacgatatctctcag

negSeV_12

tcagaagagcctgaatacct

negSeV_13

catataccacgacatcgtgt

negSeV_14

actgatgcttatccattgtc

negSeV_15
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gtattcctaacccatgacaa

negSeV_16

atttcggaaccatcggagag

negSeV_17

gacacaaaatgccggtgttc

negSeV_18

cttgagaatgggtgcggaac

negSeV_19

taatggatgtgaatccccat

negSeV_20

gtcaatgggacatctctagg

negSeV_21

ctggtccagataagaaagcc

negSeV_22

cgtagatccaatctaccatc

negSeV_23

ggtggcaagactgacaacac

negSeV_24

agaggtacgaggaggtacat

negSeV_25

tacgaggcttcaaggtactt

negSeV_26

tgaatttgctccaggcaatt

negSeV_27

ggcccgatattaataagctt

negSeV_28

gagacaaagatggcagctct

negSeV_29
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CHAPTER 3: The Viral Polymerase Complex Mediates the
Interaction of vRNPs with Recycling Endosomes During Sendai Virus
Assembly

The contents of this chapter have been submitted for publication as:
Genoyer E, Kulej K, Hung C, Thibault PA, Azarm K, Takimoto T, Garcia BA, Lee B,
Lakdawala S, Weitzman M, López CB. 2020. The Viral Polymerase Complex Mediates
the Interaction of vRNPs with Recycling Endosomes During SeV Assembly.
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3. 1 Abstract
Paramyxoviruses are negative sense single-stranded RNA viruses that comprise
many important human and animal pathogens, including human parainfluenza viruses.
These viruses bud from the plasma membrane of infected cells after the viral
ribonucleoprotein complex (vRNP) is transported from the cytoplasm to the cell
membrane via Rab11a marked recycling endosomes. The viral proteins that are critical
for mediating this important initial step in viral assembly are unknown. Here we use the
model paramyxovirus, Sendai virus (SeV), recently named murine parainfluenza virus 1,
to investigate the roles of viral proteins in Rab11a-driven virion assembly. We previously
reported that infection with SeV containing high levels of copy-back defective viral
genomes (DVGs) generates heterogenous populations of cells, with cells enriched in
full-length virus producing viral particles containing standard or defective viral genomes,
while cells enriched in DVGs did not, despite high levels of defective viral genome
replication. Here we take advantage of this heterogenous cell phenotype to identify
proteins that mediate interaction of vRNPs with Rab11a. We examine the role of matrix
protein and nucleoprotein and determine that they are not sufficient to drive interaction of
vRNPs and recycling endosomes. Then, using a combination of mass spectrometry and
comparative protein abundance and localization in DVG- and FL-high cells, we identify
viral polymerase complex components L and, specifically, its cofactor C proteins as
interactors with Rab11a. We find that accumulation of these proteins within the cell is the
defining feature that differentiates cells that proceed to viral egress from cells which
remain in replication phases.
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4.2 Significance
Paramyxoviruses are a family of viruses that include a number of pathogens with
significant burdens on human health. Particularly, human parainfluenza viruses are an
important cause of pneumonia and bronchiolitis in children and do not have any
vaccines or direct acting antivirals. These cytoplasmic replicating viruses bud from the
plasma membrane and coopt cellular endosomal recycling pathways to traffic viral
ribonucleoprotein complexes from the cytoplasm to the membrane of infected cells, yet
the viral proteins required for viral engagement with the recycling endosome pathway is
not known. Here we use the model paramyxovirus Sendai virus, or murine parainfluenza
virus 1, to investigate the role of viral proteins in this initial step in viral assembly. We
find that viral polymerase components large protein L and accessory C proteins are
necessary for engagement with recycling endosomes. These findings are important in
identifying viral targets for the development of antivirals.
4. 3 Introduction
Paramyxoviruses, as well as orthomyxoviruses and hantaviruses, use the
recycling endosome pathway as a controlled mechanism of egress to traffic vRNPs from
the infected cell cytoplasm to the cell membrane(45). Rab11a, a host GTPase
associated with recycling endosomes, is critical for the transport of cargo from early
endosomes to the perinuclear endocytic recycling complex and back to the plasma
membrane(196). Paramyxoviruses that rely on Rab11a for intracellular transport and
viral egress include SeV(47), measles(50), mumps(49), and HPIV1(47). While it is
known that the vRNP interacts with Rab11a, it is not known which viral proteins are
necessary to drive this critical interaction required for viral particle assembly. In fact,
while multiple proteins including M and C have been investigated for their role in driving
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viral assembly, their roles remain contested and poorly understood (20). For example,
SeV M has been reported to interact with vRNPs in the cytoplasm and be required for
recruitment of vRNPs to the membrane (191, 192) but has also been shown to traffic
with surface proteins F and HN via the trans-golgi network (190). Whether the M protein
is critical for engagement of SeV vRNPs with Rab11a marked endosomes is unknown.
Further, in addition to the C proteins’ roles in innate immune antagonism and
polymerase function, they have also been reported to be enhancers of particle formation
(68, 70). Data has suggested that C is critical in recruiting vRNPs to the membrane (70),
and that C expression enhanced association of vRNPs to membranes. Additionally, both
C and M proteins have been shown independently to recruit Aip1/Alix, a protein involved
in endosomal sorting and vesicle budding, to the plasma membrane to enhance virion
formation(67, 68). But the requirement for Aip1/Alix in paramyxovirus budding is
contested with evidence that absence of Aip1/Alix in cells does not have any effect on
SeV particle formation(69). Thus, while both C and M have been heavily studied in the
context of particle assembly, a clear picture of how these proteins function in early steps
of assembly is lacking.
We previously reported that upon infection with DVG-containing virus
populations, cells display a heterogenous phenotype with the development of
subpopulations of DVG-high cells and full-length (FL)-high cells(165, 197). DVG-high
cells contain higher levels of DVGs than full length genomes, and FL-high cells contain
higher levels of full-length genomes than DVGs. Not only do these subpopulations have
distinct transcriptional profiles(165), but they have different intracellular localizations of
viral RNA(vRNA) (197). The vRNA in FL-high cells interacts with recycling endosomes
and this leads to the production of both standard and defective viral particles, while the
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vRNA in DVG-high cells does not interact with recycling endosomes and consequently
these cells do not produce significant amounts of viral particles. However, these DVGhigh cells undergo robust levels of vRNA replication as evidenced by the large increase
in DVG RNA by qPCR and vRNA fluorescent in situ hybridization (FISH) over time(165)
(197). In this chapter, we take advantage of DVGs as a system to investigate early steps
that differentiate viral replication from viral particle production, namely how vRNPs
interact with Rab11a, and describe the viral polymerase components L and C as
differentiating factors in FL-high cells that facilitate vRNP association with recycling
endosomes and subsequent viral assembly.
3.4 Results
3.4.1 M protein interacts with NP primarily at the cell surface and does not localize with
Rab11a
Though SeV matrix protein (M) is necessary for SeV particle assembly(20),
whether it is required for the association of vRNPs to recycling endosomes is unknown.
It has been proposed that M is targeted to the plasma membrane together with the F and
HN proteins(190) and, conversely, to traffic with vRNPs from the cytoplasm to the
plasma membrane(191). In order to investigate whether the M protein is responsible for
the association of vRNPs with recycling endosomes, we created a recombinant SeV with
an HA-tag on the N-terminus of the M protein (SeV-M-HA) to study its localization during
infection. We characterized this virus to ensure that the HA-tag did not result in a
dramatically different growth curve from the parental SeV F1R strain (SeV-F1R) and
found that while viral output was slightly lower at later time points in infection, virion
production was largely unimpaired (Fig. 3.1A). We then examined the localization of M
during infection. Consistent with the fact that M lines the inside of virions and budding
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occurs from the plasma membrane, we observed M at the plasma membrane of infected
cells (Fig. 3.1B-D). Interestingly, single plane confocal images show little overlap of NP
and M proteins (Fig. 3.1B).
As we previously reported, when Rab11a is knocked down by siRNA or when
microtubule polymerization is disrupted, the perinuclear localization of viral RNA is
altered(197). To ask if M interacted with the Rab11a/microtubule pathway, we assayed
the localization of M upon treatment with nocodazole, a drug that prevents microtubule
polymerization. In agreement with previously published data, nocodazole treatment of
FL-high cells disrupted perinuclear clustering of the viral NP, indicating that vRNPs are
tethered to microtubules via recycling endosomes(197). In contrast, M protein
distribution was not drastically altered when cells were treated with nocodazole and it
still localized at the plasma membrane (Fig. 3.1C). These data support a model whereby
the M protein is trafficked to the cell plasma membrane independently of the microtubule
network, implying that the M protein it is unlikely to be critical in driving interaction
between vRNPs and recycling endosomes.
It has also been reported that DVGs lead to increased degradation and turnover
of M(155). Therefore, if M is the protein responsible for tethering vRNPs to recycling
endosomes, it is possible that DVGs in DVG-high cells fail to interact with Rab11a due to
insufficient levels of M to drive this interaction. To address this possibility, we
overexpressed M-FLAG in cells infected with SeV Cantell strain with a high level of
DVGs (HD) which generates a heterogenous population of DVG-high and FL-high
cells(165, 197) and asked whether high levels of M were sufficient to drive a perinuclear
localization of DVGs. For these experiments we used 293T cells because they allow for
infection and subsequent transfection of the same cell. We confirmed using vRNA FISH
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to distinguish DVG from gSeV RNA (Fig. 3.1D) that the distinct intracellular distribution
of FL-high and DVG-high cells was conserved in these cells. Overexpressed M localized
to the membrane of infected cells, as expected. However, overexpression of M in DVGhigh cells failed to recruit DVGs to the perinuclear region with DVGs remaining
distributed throughout the host cell cytoplasm (Fig. 3.1E). These data indicate that M is
not sufficient to drive association between vRNPs and recycling endosomes.
Finally, to confirm that M was not responsible for driving interactions between
vRNPs and recycling endosomes, we infected A549 Rab11a-mcherry cells with SeV low
DVG (LD) viruses, in which all vRNPs should interact with Rab11a(197), and performed
immunofluorescence for various viral proteins (Fig. 3.2A) and compared their
colocalization with Rab11a (Fig. 3.2B). As previously reported (197), in SeV LD
infections NP and Rab11a colocalize in the perinuclear region. In contrast, M largely
does not colocalize with Rab11a (Fig. 3.2B). We also examined the colocalization of
Rab11a with other viral proteins, including the polymerase L and C proteins. We found
that C also colocalizes with Rab11a to the same extent as NP, and that L colocalizes to
an even higher degree than NP or C. This indicates that at this timepoint of infection,
most or all L proteins are associated with recycling endosomes, while excess free NP
and the pool of C proteins which antagonize innate immunity do not. Overall, these data
support a model whereby vRNPs associate with Rab11a independent of M and likely
through members of the polymerase complex L and C. In addition, our data support the
model of interaction between M and the vRNPs occurring at the plasma membrane.
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Figure 3.1. Matrix protein localization to the plasma membrane occurs independently of
microtubules/Rab11a. A) TCID50/mL of supernatant from LLCMK2 cells infected with SeV-MHA and SeV F1R (parental wildtype) at indicated timepoint, n = 3, graphed as mean ± SEM. B)
A549 cells infected with SeV-M-HA for 24 hpi, immunofluorescence for SeV NP (red), HA (SeV
M, green), Hoechst (nuclei, blue). Confocal 63x, 2x digital zoom. Panels 1-3 showing extended
focus, panel 4 showing cropped single XY plane as well as XZ and YZ planes. C) A549 cells
infected with SeV-M-HA, treated with nocodazole or DMSO vehicle control at 4hpi,
immunofluorescence at 24 hpi for SeV NP (red), HA (SeV M, green), Hoechst (nuclei, blue). 63x
widefield deconvoluted, max projection shown. D) Schematic of vRNA FISH to detect (-)gSeV
and (-)DVG RNA, indicating red and green probe binding regions. E) 293T cells infected with SeV
Cantell HD then transfected with SeV M-FLAG at 6hpi, vRNA FISH with immunofluorescence for
FLAG (SeV M, gray) at 24hpi. 63x widefield deconvoluted, max projection shown. Magenta
arrows indicate infected and transfected cells. All images are representative of 3 independent
experiments, scale bar = 20µm.

Figure 3.2. vRNP components colocalize with Rab11a but SeV M does not A) A549-Rab11mcherry cells infected with SeV M-HA (M and NP), SeV Cantell LD (C), or SeV LeGFP (L) for 24
hours. Immunofluorescence for viral antigens (purple), mcherry-Rab11a shown in (green).
Confocal 63x images, 1.5x zoom, max projection shown. All images are representative of 3
independent experiments, scale bar = 20µm. B) Quantification of colocalization between viral
proteins and Rab11a, pooled from three independent experiments with >20 cells analyzed per
experiment. Individual cells are plotted with line at the mean and error bars represent SD. ****=
p<0.0001, ** = p<0.01 by One-way ANOVA with Sidak’s multiple comparisons test.
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3.4.2 Nucleoprotein coverage of vRNPs is not sufficient to drive interaction with Rab11a
Because we observed that NP, L, and C proteins all colocalized with Rab11a
during infection, we next sought to address which of these proteins was important for the
interaction of vRNPs with recycling endosomes. First, we asked whether NP was
sufficient for driving this interaction. As the most abundant protein on the vRNP, it is
possible that NP coverage of the viral genome dictates engagement with Rab11a. We
reasoned that if NP coverage of vRNPs was critical for interaction with Rab11a, the lack
of engagement of vRNPs with Rab11a in DVG-high cells may be explained by high
levels of free or partially coated vRNA. In order to investigate whether viral RNA in DVGhigh cells was coated in NP we tested for colocalization of these NP and viral genomes
using RNA FISH combined with immunofluorescence for NP (Fig. 3.3A). To confirm the
association of NP with DVG RNA, we quantified colocalization of 5’(-)SeV RNA with SeV
NP (Fig. 3.3B-D). As shown in (Fig. 3.1D) the 5’(-)SeV probe set binds to all species of
negative sense vRNA in cells. In DVG-high cells, the majority of vRNA recognized by 5’() SeV probe RNA corresponds to DVGs, but in FL-high cells it corresponds primarily to
FL-genome RNA as indicated. We found that there was no significant difference in the
colocalization between viral RNA and SeV NP in DVG-high and FL-high cells (Fig.
3.3B). Mander's overlap coefficient (MOC) indicates the portion of a signal that overlaps
with the other signal in question, regardless of signal intensity. The MOC for NP with
viral RNA showed that nearly all NP in DVG-high cells overlapped with viral genomes,
but a lower fraction of SeV NP overlapped with vRNA in FL-high cells, presumably due
to excess free NP that is not coating viral genomes (Fig. 3.3C). The MOC for 5’(-)SeV
RNA overlap with NP was equivalent between DVG-high and FL-high cells, indicating
that all equal portions of viral RNA colocalized with NP (Fig. 3.3D).
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Figure 3.3. Nucleoprotein association is similar between full-length and defective viral
genomes A) A549 cells infected with SeV Cantell HD for 24 hours and then subjected to RNA
FISH with immunofluorescence for NP (gray), Hoechst (nuclei, blue). Confocal 63x image, 1.5x
zoom, single plane image shown. Images are representative of three independent experiments,
scale bar = 20µm. B) Costes’s Pearson’s correlation of colocalization between (-)5’SeV and SeV
NP in individual DVG-high and FL-high cells. C) Mander’s overlap coefficient of NP with 5’ SeV in
DVG-high and FL-high cells D) Mander’s overlap coefficient of 5’SeV with NP in DVG-high and
FL-high cells. Individual cells pooled from three independent experiments are plotted with line at
the mean and error bars representing SD. **** = p<0.0001 by Mann-Whitney U-test. E) CT values
for qPCR for viral RNA, DVG RNA, and GAPDH with and without RNase A, V1, and T1 treatment
after immunoprecipitation with anti-SeV NP. F) Fold change in RNA levels in RNase treated
immunoprecipitation products relative to untreated. Data from four independent experiment are
shown, with line at the mean and error bars representing SEM.
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Though DVGs appear to be associated with NP, we wondered whether NP
coating of DVGs was complete. We reasoned that there may be regions of exposed
RNA that may disrupt the helical structure of the vRNP and therefore prevent
interactions with host factors. To assess the integrity of the vRNP we performed an
immunoprecipitation (IP) of NP from infected cells and subjected the IP product to
RNase digestion with a combination of RNase A, V, and T1, targeting both single and
double stranded RNA. RNA was then extracted and analyzed by RT-qPCR to compare
levels of viral RNA to untreated controls. There was no significant difference in RNA
quantities between DVG RNA and full-length vRNA in treated and untreated conditions
(Fig. 3.3E). We also tested unbound fractions of the pulldown, reasoning that if there
was any free RNA it would not be precipitated by anti-NP antibody. Both vRNA and DVG
RNA where found in the unbound fraction indicating that the IP did not precipitate all of
the vRNPs, but the RNA in this fraction was also not significantly different between
treated and untreated conditions, particularly in comparison to an abundant cellular
mRNA, GAPDH (Fig. 3.3F). These data do not preclude that there is some degree of
uncoated RNA in DVG-high cells, but it indicates that the vast majority of vRNPs present
during high DVG infections are sufficiently coated in NP. These data indicate that while
NP and the vRNP associate with Rab11a in FL-high cells, NP coating of viral genomes
is not sufficient to drive association with recycling endosomes and is likely not providing
a direct link between viral genomes and Rab11a.
3.4.3 DVG driven interference leads to strong decrease in L transcripts and protein
Accumulation of DVGs leads to a decrease in standard viral genome replication
and viral protein accumulation, a phenomenon known as interference. This interference
is due to DVGs competing for viral polymerase and other proteins necessary for viral
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replication (159, 175). In order to take a more systematic approach to the examination of
the role of viral proteins in viral assembly, we investigated whether the interference
effect resulting from high levels of DVGs had an equal impact across viral proteins or
whether there were certain viral mRNAs and proteins most drastically impacted by
interference. The hypothesis was that those proteins most interfered with by DVGs are
essential for the localization of vRNPs to recycling endosomes and in their absence
vRNPs, including DVG vRNPs, mislocalize within the cytoplasm.
The transcription of paramyxovirus mRNA is directed by the RdRP beginning at
the 3’ end of the genome and progressively losing processivity to generate a gradient of
mRNA, with highest levels of the 3’ proximal genes and lowest levels of the 5’ genes(14,
27) produced (Fig. 3.4A). To determine whether interference with mRNA transcription by
DVGs had a more drastic effect on some viral mRNAs compared to others, we
performed qPCR on viral RNA from SeV LD and HD infected cell populations at 12
hours post infection, the time at which there is the highest rate of mRNA accumulation
compared to genome accumulation(31, 197). As expected, we observed a gradient of
transcription with higher levels of the 3’ proximal transcripts and lowest amounts of L
mRNA. Additionally, SeV HD infections had lower levels of viral mRNA levels across all
genes (Fig. 3.4B). However, when comparing the levels of each mRNA across infections
to normalize for differences in mRNA levels, it became clear that the levels of L mRNA
were most significantly decreased (Fig. 3.4C). Because the SeV HD infections includes
both FL-high and DVG-high cells, it is likely that levels of mRNA in DVG-high cells were
even further reduced compared to levels of viral mRNA in LD infections, which contains
mostly FL-high cells.
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Figure 3.4 L mRNA and protein is significantly reduced in DVG-high cells compared
to other viral proteins A) Schematic of gene organization and gradient mRNA
transcription in SeV. (B) A549 cells infected with SeV Cantell LD and SeV Cantell HD for
12 hours, qPCR for viral genes shown as relative copy number compared to GAPDH and
(C) relative amount in SeV HD infections compared to SeV LD infection for each viral gene.
** = p< 0.01, * = p<0.05 by One-way ANOVA with Sidak’s multiple comparisons test. (D-F)
A549 cells infected with SeV Cantell LD and SeV Cantell HD for 24 hours were subjected
to RNA FISH combined with antibody staining for flow cytometry. (D) Representative flow
plots for each condition with gates for DVG-high cells highlighted in green, and FL-high
cells highlighted in red, and cells below limit of detection for viral RNA by flow in blue. (E)
Representative MFI plot showing MFI of viral proteins in different cell populations in HD
infected cells with FL-high cells shown in red and DVG-high cells shown in green, mock
cells shown with dashed line. (F) relative MFI in DVG-high cells compared to FL-high cells
in SeV HD infected conditions, four independent experiments are shown with bars
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representing the mean and SD. * = p<0.05 by one-way ANOVA with Sidak’s multiple
comparison’s test.

To determine whether decreases in viral mRNA transcription translate to lower
levels of viral protein, we quantified protein levels in DVG-high and FL-high cells. SeV
HD infections were subjected to RNA FISH flow coupled with immunostaining for
different viral proteins. RNA FISH-flow cytometry allows for the identification of discrete
cell populations based on intensity of 3’- and 5’- SeV probes in each cell, using the same
strategy as in imaging (Fig. 3.1D). Using this method we are able to define DVG-high
and FL-high populations (Fig. 3.4D) as validated in(165). We then calculated the mean
fluorescence intensity as a proxy for viral protein amount in each of the identified
populations (Fig. 3.4E). Levels of protein in DVG-high cells was normalized to FL-high
cell levels (Fig. 3.4F). Levels of all viral proteins were lower in DVG-high cells compared
to FL-high cells, recapitulating the mRNA data. These data show that the proteins that
are the least abundant are most sensitive to DVG mediated interference as there is a
much greater reduction of L protein in DVG-high cells than other viral proteins (Fig.
3.4F). This observation suggests that the L protein may be an important factor in
regulating interactions of vRNPs with recycling endosomes, as this is the most strongly
differentiating factor between DVG-high and FL-high cells.
3.4.4 SeV C proteins interact with Rab11a
We next used an unbiased approach to determine which viral proteins interact
with Rab11a. To do this, we infected Rab11a-GFP A549 cells with SeV LD followed by
immunoprecipitation (IP) of Rab11a using antibodies against GFP at 12 and 24 hours
post infection to identify interacting proteins. By using SeV LD virus stocks we ensure
that all cells are have vRNPs that are interacting with Rab11a. We also performed mass
spectrometry on whole cell lysates. At 12 hours post infection, we identified viral proteins
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present in a gradient of abundance with highest levels of NP and lowest levels of L and
accessory proteins C and V (Fig. 3.5A) recapitulating the gradient of viral mRNA
observed in (Fig. 3.4B). We identified high levels of NP, M, and C proteins in the
Rab11a IP (Fig. 3.5B). C proteins are the most highly enriched viral proteins when
normalized to levels of viral protein found in whole cell lysates (Fig. 3.5C), which was
done to differentiate proteins that were enriched due to interactions with Rab11a from
proteins simply increasing in abundance after viral infection. Similar results are observed
at 24 hours post infection, with the magnitude of viral proteins increasing overall but
trends staying the same (Fig. 3.5D-F). We also compared the log fold change of
proteins identified by IP at both 12 hours post infection (Fig. 3.5G) and 24 hours post
infection (Fig. 3.5H) and identified the C proteins as the most significantly enriched viral
protein interacting with Rab11a compared to mock at both time points. Additionally, L
protein is identified as significantly enriched at 24 hours post infection. To validate these
results, we performed a western blot and probed for Rab11a and various viral proteins
(Fig. 3.5I). As expected, Rab11a was enriched after IP, while the viral protein P was not
seen, corresponding with its absence in the mass spectrometry analysis. C protein has
the highest ratio of IP to input, strongly suggesting that the C protein most directly
interacts with Rab11a. Both NP and M proteins are moderately present in the IP and
likely represent high levels of protein in the cell (NP) and potential interactions between
Rab11a and M which may occur at the plasma membrane in late stages of particle
formation as shown in Figure 1. Because SeV generates 4 C proteins that are described
to have discrete functions(198), we asked whether we could identify which C protein was
interacting with Rab11a. The four C proteins range in size from 175 to 215 amino acids
and share a common 175 amino acid C-terminus. We mapped the peptide reads
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Figure 3.5. C proteins identified to interact with Rab11a by immunoprecipitation and mass
spectrometry A) Normalized protein abundance for viral proteins identified by mass
spectrometry at 12 hpi. B) Normalized protein abundance of viral proteins identified by IP of
Rab11-GFP at 12 hpi. C) Relative protein abundance of proteins identified by IP to total protein
abundance in whole cell lysates at 12hpi. D) Normalized protein abundance for viral proteins
identified by mass spectrometry at 12 hpi. E) Normalized protein abundance of viral proteins
identified by IP of Rab11-GFP at 12 hpi. F) Relative protein abundance of proteins identified by IP
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to total protein abundance in whole cell lysates at 12hpi. A-F, three independent experiments are
plotted with bar representing mean, error bar representing SD. G) Volcano plot comparing mock
to 12 hpi and normalized to input or total abundance H) and comparing mock to 24 hours post
infection and normalized to input. Data is pooled from three independent experiments. Viral
proteins are indicated. Dark blue dots represent p>0.05 and light blue dots represent p<0.05 by
student’s t-test. I) Validation of mass spectrometry by western blot probing for Rab11a or viral
proteins at 24 hours post infection and quantified for relative band intensity of IP over input. J)
Schematic of C proteins with locations of peptides identified by mass spectrometry in IP samples
marked in purple.

identified by in the IP by mass spectrometry to the C proteins (Fig. 3.5J) and found they
were all from the shared 175 amino acid region, and therefore we could not conclude
which specific protein(s) were identified. Overall, the identification of C proteins as a
likely interactor of Rab11a by immunoprecipitation and subsequent mass spectrometry
recapitulate results showing high degrees of colocalization as shown in (Fig. 3.2A-B)
and suggests C proteins play an important role in directing interaction of vRNPs with
recycling endosomes.
3.4.5 Occupancy of polymerase proteins on viral genomes is the differentiating factor in
vRNPs that interact or fail to interact with Rab11a
Because we found that the L protein was lowest in DVG-high cells when
comparing DVG-high and FL-high cells and identified its cofactor C by mass
spectrometry as a Rab11a interacting partner, we considered whether differences in
polymerase component levels may drive differences in engagement with Rab11a in
DVG-high and FL-high cells. To ask whether polymerase was associated with viral RNA
in DVG-high cells we performed RNA FISH combined with immunofluorescence. To
visualize L we used a recombinant SeV with C-terminus fused GFP (SeV LeGFP) that
has been previously described(48) and the addition of purified defective particles
containing DVG-546, the dominant DVG in SeV Cantell. Previous studies have validated
the ability of other strains of SeV to replicate DVGs from heterologous strains(197).
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During infection with SeV LeGFP in the presence of purified defective particles (pDPs),
we see the establishment of DVG-high cells, and strikingly these cells have very low
levels of L protein (Fig. 3.6A), recapitulating flow cytometry results that showed large
differences in the amount of L protein in DVG- and FL-high cells. Additionally, it appears
that a majority of DVG RNA in DVG-high cells is not bound by L protein. Indeed,
colocalization of 5’(-)SeV RNA and L was significantly lower in DVG-high cells compare
to FL-high cells (Fig. 3.6B). The MOC of L is equivalent in DVG-high and FL-high cells,
indicating that the same proportion of L in each cell is interacting with vRNA, indicating
that the small amount of polymerase present in those cells is colocalized with DVG RNA
(Fig. 3.6C). However, the MOC of 5’ (-) SeV RNA with SeV L was significantly lower in
DVG-high cells compared to FL-high cells, indicating that a smaller fraction of viral RNA
overlaps with L in DVG-high cells than in FL-high cells and that there are many DVG
RNAs that are not occupied by a polymerase in DVG-high cells (Fig. 3.6D). The small
amount of L protein in DVG-high cells is likely associated with DVGs for replication, but
the majority of DVGs within the cytoplasm of DVG-high cells are not associated with L.
This strong difference in L interaction with viral RNA in DVG-high and FL-high cells
indicates that L protein may be critical in driving vRNPs to interact with Rab11a.
As levels of and engagement with the polymerase seems to be a differentiating
factor between DVG-high and FL-high cells, we sought to investigate whether these
differences were found with C protein as well. Upon RNA FISH combined with
immunofluorescence for C protein, we observed similar results to those seen with SeV L,
with low levels of C protein in DVG-high cells and a perinuclear localization of C protein
in FL-high cells (Fig. 7A), indicating indeed that at later timepoints of infection, C protein
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Figure 3.6. L protein interaction with vRNP distinguishes between DVG-high and FL-high
cells A) A549 cells infected with SeV LeGFP supplemented with purified DPs (HAU 20) for 24
hours and then subjected to RNA FISH with immunofluorescence for GFP (L, gray), Hoechst
(nuclei, blue). Confocal 63x image, 1.5x zoom, single plane image shown. Images are
representative of four independent experiments, scale bar = 20µm. B) Costes’s Pearson’s
correlation of colocalization between (-)5’SeV and SeV NP in individual DVG-high and FL-high
cells. C) Mander’s overlap coefficient of L (GFP) with 5’ SeV in DVG-high and FL-high cells D)
Mander’s overlap coefficient of 5’SeV with L (GFP) in DVG-high and FL-high cells. Individual cells
pooled from three independent experiments are plotted with line at the mean and error bars
representing SD, **** = p<0.0001 by Mann-Whitney U-test.

associates with vRNA and presumably L. Quantification of colocalization revealed that
there is a significantly greater degree of colocalization of C and 5’(-)SeV RNA in FL-high
cells compared to DVG-high cells, indicating that like with L protein, many DVG vRNPs
are not occupied by C protein (Fig. 7B). MOC of SeV C reveals that higher proportions
of C are colocalized with 5’ (-) SeV RNA in DVG-high cells than in FL-high cells (Fig.
7C). However, MOC of 5’ (-) SeV RNA with SeV C indicates that in FL-high cells, a high
proportion of vRNA overlaps with C, while in DVG-high cells, much of the vRNA does not
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overlap with C proteins (Fig. 7D). These data indicate, that similarly to L protein, low
levels of C proteins in DVG-high cells seem to colocalize with DVG-RNA but that very
low levels of C protein in the cell leave many RNAs unbound by these proteins. Taken
together, these data suggest that lack of accumulation of C and L proteins in DVG-high
cells and therefore lack of C and L proteins bound to vRNPs precludes these vRNPs
from interacting with Rab11a.

Figure 3.7. C protein interaction with vRNP distinguishes between DVG-high and FL-high
cells A) A549 cells infected with SeV Cantell for 24 hours and then subjected to RNA FISH with
immunofluorescence for C (gray), Hoechst (nuclei, blue). Confocal 63x image, 1.5x zoom, single
plane image shown. Images are representative of four independent experiments, scale bar =
20µm. B) Costes’s Pearson’s correlation of colocalization between (-)5’SeV and SeV C in
individual DVG-high and FL-high cells. C) Mander’s overlap coefficient of C with 5’ SeV in DVGhigh and FL-high cells D) Mander’s overlap coefficient of 5’SeV with C in DVG-high and FL-high
cells. Individual cells pooled from two independent experiments are plotted with line at the mean
and error bars representing SD **** = p<0.0001 by Mann-Whitney U-test.

82

3.5 Discussion
We propose a model of Sendai virus assembly in which polymerase components
including the viral polymerase L and its cofactor C are critical for the interaction between
viral RNPs and Rab11a, a crucial initial step in viral particle production. In taking
advantage of the difference in viral particle production in DVG-high and FL-high cells we
parsed viral components that are critical for replication and those that are critical for viral
assembly. DVG-high cells are able to carry out robust levels of viral genome replication
using limited amounts of L but are unable to produce virions because they do not
engage with host proteins critical for this process(197). We observed that DVG
interference with viral protein expression critically diminishes levels of the viral
polymerase L in DVG-high cells and we propose that L/C accumulation above a certain
threshold is required for interaction of the vRNP with recycling endosomes and the
cellular trafficking machinery. Further, we identified the C proteins as the most highly
enriched viral proteins interacting with Rab11a by mass spectrometry. From these data
we propose that recycling endosomes interacts with C proteins when it is bound to L,
and that C-L polymerase complexes interact with vRNPs to tether then to recycling
endosomes (Fig. 3.8).
It remains to be determined whether paramyxoviruses interact directly with
recycling endosomes via endosomal membrane interactions, with the Rab11a GTPase
itself, with family-interacting proteins (FIPs) associated with Rab11a or via another
mechanism. The different Rab11-FIPs direct engagement of Rab11a-marked recycling
endosomes with dynein or myosin Vb motor proteins, and specific FIPs have been
identified as important for budding of different viruses. For example Rab11-FIP2 is
important for respiratory syncytial virus budding(53) and influenza relies on Rab11-FIP3
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for filamentous particle production(52). The Rab11a-FIPs used for trafficking of SeV are
unknown and identifying a viral protein that mediates interaction with recycling
endosomes will aid further study of these dynamics.

Figure 3.8. Model of SeV vRNP interaction with Rab11a. Viral replication occurs in the
cytoplasm and upon accumulation of sufficient levels of L and C proteins, vRNPs interact
with Rab11a-marked recycling endosomes via C and L proteins, in order to be trafficked to
the plasma membrane.

Negative-sense RNA viruses require packaging of RdRPs within virions to initiate
infection. Indeed, SeV L proteins have been shown to associate with viral nucleocapsids
isolated from virions(199). Additionally, C proteins have been found to be tightly
associated with nucleocapsid structures both inside the cell as well as when isolated
from SeV virions, with approximately 40 C proteins per vRNP(200). The observed role of
polymerase components in assembly are in accordance with what was observed in
infections with the orthomyxovirus influenza, where influenza virus RNPs interact with
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Rab11a via one of its polymerase components PB2(201, 202). Like has been suggested
for influenza, having the polymerase complex initiate packaging via interactions with
Rab11a could be a mechanism to ensure that only vRNPs that contain a RdRP, and are
thus infectious, can be packaged into virions.
Most paramyxoviruses encode a number of accessory proteins off of the P gene,
either through RNA editing leading to interferon antagonist V and W families, or by
translating alternate reading frames from the P mRNA(74) to generate C family
members. While we propose that C proteins are critical for engagement with Rab11a, we
believe that in the absence of accumulation of sufficient L protein, vRNPs would be
unable to interact with Rab11a.Thus, even if, for example, levels of C protein were
higher in DVG-high cells, we would not expect to see C interacting with vRNPs in the
absence of L. Additionally, the specific mechanisms that dictate translation of the C
proteins (C, C’, Y1 and Y2) from the P mRNA are unknown. Therefore, how DVGmediated interference affects C protein accumulation is unclear. Further, while the C
proteins have been described to have discrete functions in regulating pathogenesis and
mRNA and vRNA synthesis(198), our results are unable to distinguish if a specific C
protein is required for interaction with Rab11a or if they are interchangeable. The
specific C proteins required for SeV assembly, and whether C family proteins of other
paramyxoviruses play similar or distinct roles in viral assembly are as of yet unknown.
Discerning their function in assembly could provide specific targets for the development
of direct acting antivirals.
We also investigated the role of SeV M in viral assembly. M lines the inside of
virions and interacts directly with nucleoproteins(192, 203). These contacts between M
and the nucleoproteins drive virus-specific viral particle production, as studies combining
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M and nucleoproteins from the closely related SeV and HPIV1 fail to lead to particle
production(58). While M-NP contacts are important for particle production, it is unknown
whether M is delivered to the cell membrane with nucleoproteins or independently, and
whether its transport relies on Rab11a (20). Our experiments indicate that M is
independently trafficked to the plasma membrane and is not the key mediator in vRNP
interactions with Rab11a. Our data is consistent with previous reports that indicate that
M traffics with F and HN through the trans-golgi network (TGN) to the cell
membrane(190). We also identify M in the Rab11a IP-mass spectrometry results.
Though we don’t see strong enrichment of M in the IP when validated by western blot, it
is possible that interactions with Rab11a are occurring at the plasma membrane.
Alternatively, if M is trafficked to the membrane with surface proteins F and HN as
proposed by (190), Rab11a may be interacting with M near the TGN. There is evidence
that the rhabdovirus vesicular stomatitis virus (VSV) glycoprotein, which is processed in
the TGN, requires Rab11a for proper sorting to the plasma membrane(204). Therefore, it
is possible that SeV M, F, and HN may interact with Rab11a during their transit from the
TGN to the plasma membrane.
It is well established that DVGs exert effects on viral infections through interfering
with standard viral genomes by competing for structural proteins or viral polymerase(92).
DVGs have been reported to globally lower levels of viral proteins within infected cells
and for that reason have been investigated as antivirals themselves(114). Whether all
viral proteins are equally affected by interference has not been previously reported.
While it has been shown that infections with SeV HD leads to lower levels of M protein,
these lower levels were attributed to increased degradation of M(155). Presence of
DVGs have also been shown to lead to lower levels of HN on the surface of infected
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cells(156). We performed a systematic investigation of the effects of interference on
levels of mRNA and protein levels by directly comparing FL-high cells and DVG-high
cells from a heterogenous infection. Our results support previous finding of lower levels
of M and HN in the presence of DVGs but reveal that DVG interference with L mRNA
transcription leads to significantly lower amount of mRNA and subsequent lower protein
translation in DVG-high cells. Because L is the lowest abundance mRNA and protein,
DVG-driven interference has the highest impact on its abundance. The gradient
expression of mRNA as well as copy-back DVGs are unique to single-stranded negative
sense RNA viruses. However, other RNA viruses, such as influenza produce deletion
DVGs and are known to be sensitive to DVG-driven interference. It has been shown that
DVGs generated from certain segments can exert different levels of interference
pressure(205), but not whether interference particularly affects the accumulation of
certain mRNAs or proteins. The role that DVG-mediated interference may play in
restricting viral progeny production via reduction of certain key proteins in other viral
families remains to be investigated.
Overall, we have shown that polymerase cofactors may be critical in inducing
primary steps of viral assembly using DVGs as a tool to understand differences in viral
replication and viral assembly. While we propose that C and L proteins are essential for
driving contact between vRNPs and Rab11a during SeV infection, whether intricacies of
viral assembly are conserved across paramyxoviruses is unknown. Many studies
suggest that there are at least subtle differences amongst the viruses in their intracellular
localization, transport, and eventual assembly(20). Because DVGs have been identified
from most paramyxoviruses, comparisons between DVG-high and FL-high cells during
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infection may be useful in parsing proteins required for viral replication from those
required to initiate virion assembly of other members of the viral family.
3.6 Materials and Methods
Cells
A549 (human type II pneumocytes, ATCC CCL-185) and LLCMK-2 (monkey kidney
epithelial cells, ATTC CCL-7) were maintained in Tissue Culture Medium (DMEM
(Invitrogen) supplemented with 10% Fetal Bovine Serum (Sigma), Gentamicin
(ThermoFisher), Sodium Pyruvate (Invitrogen), L-glutamine (Invitrogen)) at 7% CO2,
37°C. A549 Rab11-GFP and A549 Rab11-mCherry cells were generated as described in
(202). Cells were tested monthly for mycoplasma MycoAlert Mycoplasma detection kit
(Lonza) and treated with Mycoplasma Removal Agent (MP Biomedical) upon thawing.
Viruses
Sendai virus Cantell was grown in 10-day embryonated specific pathogen free chicken
eggs (Charles River) for 40 hours before allantoic fluid was collected. Low DVG and high
DVG stocks were produced as previously described, and defective particles (pDPs) were
purified from allantoic fluid infected with SeV Cantell by density ultracentrifugation on a
5-45% sucrose gradient. SeV-LeGFP is a recombinant Enders strain of virus described
in(48). SeV-LeGFP cells was grown for 72 hours in LLCMK2 cells. SeV-M-HA virus was
generated with an HA tag at the N-terminus of the M protein in a recombinant SeV F1R
background. Virus was rescued by transfection in to BSRT7 cells as described(206) and
passaged blindly three times. Virus was then grown for 5 days in LLCMK2 cells. All
viruses were titrated using 1:10 serial dilution in triplicate in LLCMK2 cells in the
presence of 2ug/mL TPCK trypsin (Worthington Biomedical) for 72 hours and TCID50/mL
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was determined by the Reed-Meunch method based on hemagluttination of 0.5%
washed chicken red blood cells (Lampire) to indicate presence of infection.
Plasmids and Transfection
SeV-M-FLAG plasmid encodes codon optimized SeV Matrix with a 3X N-terminal FLAG
tag in the pCMV-3Tag-1A vector. Cells in antibiotic free media (8x105/6-well) were
transfected 6 hours post infection with 2ug plasmid and 6ul Lipofectamine 2000
(Invitrogen) per well diluted in Opti-MEM (Invitrogen).
Viral Infections
Infections were performed at a multiplicity of infection of 1.5 TCID50/cell unless otherwise
specified. Cells were seeded to reach 80% confluency upon day of infection (4x105
A549/well in 6 well plates). Prior to infection cells were washed twice with PBS. Virus
was diluted in infection media (DMEM (Invitrogen) supplemented with 35% BSA (SigmaAldrich), Pen/Strep (Invitrogen), 5% NaHCO3 (Sigma-Aldrich) and low volume inoculum
was added to cells for 1 hour incubation at 37°C, with shaking every 15 minutes. Cells
were then refed with 2% FBS Tissue Culture Medium.
Drug Treatment
Four h post infection, media was removed and replaced with 2% FBS tissue culture
media containing 2μg/mL Nocodazole (Sigma-Aldrich) for duration of infection.
Immunofluorescence
Cells were seeded on No. 1.5 glass coverslips (Corning) overnight prior to infection. Post
infection coverslips were rinsed in PBS then fixed for 10 minutes in 4%
Paraformaldehyde in PBS (Electron Microscopy Sciences) for 10 min. Cells were
permeabilized with 0.2% Triton-X in PBS (Sigma-Aldrich) for 10 min. Primary and
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secondary antibodies were diluted in 3% FBS in PBS and incubated at RT for 1.5 h and
1 h, respectively. Nuclei were stained with Hoechst prior to mounting coverslips on
slides using Fluoromount-G (ThermoFisher). Primary antibodies: mouse anti-SeV NP
(clone M73/2 a kind gift from Alan Portner – directly conjugated with Dylight 594 NHS
Ester (ThermoFisher)), rabbit Anti-HA-Tag (CST C29F4), mouse Anti-FLAG 9A3 (CST
8146), rabbit Anti-GFP (ab6556), mouse anti-C (clone P16, 96-6, from Toru Takimoto).
Secondary antibodies: Goat anti-Rabbit IgG (H+L) Secondary Antibody, Alexa Fluor 488
(Invitrogen), Goat anti-mouse IgG (H+L) Secondary Antibody, Alexa Fluor 647
(Invitrogen); Goat anti-mouse IgG (H+L) Secondary Antibody, Alexa Fluor 488
(Invitrogen)
RNA-FISH
Custom probe sets were designed against the SeV genome (described in(197)) and
conjugated to Quasar 570 (3’(-)SeV) and Quasar 670 (5’(-)SeV) dyes (LGC Biosearch).
For RNA-FISH microscopy, cells were seeded on No. 1.5 glass coverslips (Corning)
prior to infection. Post infection coverslips were rinsed with PBS then fixed in 3.7%
formaldehyde (ThermoFisher) for 10 min. Cells were permeabilized in 70% EtOH for 1 h
at room temperature then washed in wash buffer (2X SSC (ThermoFisher), 10%
formamide (ThermoFisher) in nuclease free water), and then subjected to hybridization
with FISH probes. For hybridization, probes were diluted to 2.5nM in hybridization buffer
(wash buffer + dextran sulfate) and applied to slides. Slides were incubated with probe
overnight at 37°C in a humidified chamber. Prior to imaging, slides were washed in wash
buffer twice (once with Hoechst to stain nuclei) then 2X SSC. Cells were mounted in
ProLong Diamond Antifade Mountant (ThermoFisher) and cured overnight at room
temperature prior to imaging. RNA FISH combined with immunofluorescence was
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modified by staining cells with antibody after permeabilization with EtOH. Cells are
stained with antibody in 1% BSA (ThermoFisher) PBS with RNaseOUT (Invitrogen) for
45 min for 1° Ab and 40 min for 2° Ab. Cells were then post-fixed for 10 min in 3.7%
formaldehyde prior to hybridization.
RNA FISH Flow Cytometry
Cells were harvested post infection by trypsinization (ThermoFisher) and centrifugation.
Cell pellets were washed in 1% FBS in PBS one time. Cell pellets were then
resuspended in 10mL ice cold methanol (ThermoFisher) and fixed and permeabilized on
ice for 10 minutes before pelleting at 1500rpm for 5 minutes. Pellets were then
resuspended in 1mL wash buffer per sample and transferred to a microcentrifuge tube
where they were washed twice. For hybridization probes were diluted to 25nM in 100ul
hybridization buffer (wash buffer + dextran sulfate) and cell pellets were resuspended in
hybridization buffers and incubated overnight at 37°C. For antibody staining, primary
antibodies were added to the hybridization buffer and incubated overnight. Posthybridization cell pellets were washed in wash buffer twice, then washed in 2X SSC
before being resuspended in anti-fade buffer (2X SSC, 0.4% glucose (Sigma), Tris-HCL
pH 8.0 (USB Corporation) with Catalase (Sigma) and Glucose Oxidase (Sigma)). For
secondary antibody staining, antibody was added to wash buffer prior to washing with
2X SSC and incubated at 37°C for 30 minutes. Flow cytometry was performed on a BD
LSRFortessa and compensation and gating was done in FlowJo_v9.9.4 (BD
Biosciences). Mock and SeV LD infections were used to inform gating of SeV HD DVGhigh and FL-high populations.
Microscopy and Image Analysis
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Images were acquired on a Leica SP5-II Laser Scanning Confocal with 63X (1.40-0.60
NA) and 100X (1.46 NA) oil-immersion objectives with pixel size 70x70nm for FISH
immunofluorescence, with z-step size of 0.13um, with 15 slices total.
Immunofluoresence images (Rab11a colocalization) were acquired with the same
parameters except for a pixel size of 40x40nm. Images were processed in Volocity
(Perkins-Elmer) and deconvolution when performed was done with Huygen’s Essential
Deconvolution Wizard using theoretical point spread function. Colocalization was
quantified in Volocity with manually defined ROI’s using automatic thresholding based on
(195).
Immunoprecipitation
Cells were lysed in NP-40 lysis buffer (Amresco) with proteinase inhibitors (Roche
Boehringer Mannheim), RNase OUT (Invitrogen) and EDTA (ThermoFisher). Protein
concentration was measured using BCA Protein Assay (ThermoFisher). For anti-NP
immunoprecipitation: 500ug of protein was incubated overnight with primary antibody
(anti-SeV NP). Protein G Magnetic Beads (EMD Millipore), 30ul per sample, were
blocked overnight with Salmon Sperm DNA (ThermoFisher) in 5% FBS/PBS. Beads
were washed and incubated with lysate/antibody for 4 hours at 4°C while rotating. For
anti-NP immunopreciptations, beads were added 3 times sequentially. Beads were then
washed with high salt lysis buffer threes times, then low salt lysis buffer once. Samples
for RNase treatment were stopped here, samples for other applications were boiled in
sample buffer for 10 minutes. For Rab11-GFP immunoprecipitation: Anti-GFP
immunoprecipitation was carried out using anti-GFP mAb magnetic beads. 500ug
lysates were incubated overnight with beads, then washed five times with wash buffer
(50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.05% NP-40).
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Sample preparation for proteomic analysis
All chemicals used for preparation of nanoflow liquid chromatography-tandem mass
spectrometry (nLC-MS/MS) samples were sequencing grade and purchased from
Sigma-Aldrich (St. Louis, MO), unless otherwise stated. Immunoprecipitated GFPRab11A interacting proteins (Rab11A IP) were eluted from the magnetic beads by the
on-beads tryptic digestion. Briefly, the beads were resuspended in 50 µl of 50 mM
triethylammonium bicarbonate, pH 8.5 (TEAB, Thermo Fisher Scientific, Waltham, MA)
and proteins were reduced using 10 mM dithiothreitol (DTT) for 1 h at room temperature
and alkylated with 20 mM iodoacetamide (IAA) in the dark for 30 min at room
temperature. Proteins were digested with trypsin (Promega, Madison, WI) at an enzymeto-substrate ratio of ∼1:50 for 12 h in a thermomixer, shaking at 900 rpm, at room
temperature. After digestion, the supernatant was removed and collected into fresh,
labelled tubes. Beads were washed twice with 50 µl of the wash buffer (50 mM TEAB pH
8.5, 5% acetonitrile) and all supernatants were merged. The samples were concentrated
to the volume of ∼100 μl by lyophilization and acetified with trifluoroacetic acid (TFA) to
a final concentration of 0.1%. The tryptic peptides were desalted using Poros Oligo R3
RP (PerSeptive Biosystems, Framingham, MA) P200 columns with C18 3 M plug (3 M
Bioanalytical Technologies, St. Paul, MN) prior to nLC–MS/MS analysis.
The whole cell proteome samples were processed using the suspension trap (S-Trap,
Protifi, Huntington, NY)(207) mini spin column digestion protocol with minor
modifications. Briefly, cells were lysed in 300 μl of lysis buffer (5% SDS, 50 mM TEAB
pH 7.55, Halt™ protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific,
Waltham, MA)) by vortexing and probe tip sonication at 4 °C. The lysate was clarified by
centrifugation at 13,000×g for 10 min, at 4 °C. Protein concentration was measured by
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Bradford protein assay (Thermo Fisher Scientific) and ~300 µg of reduced and alkylated
proteins was subjected to trypsin digestion following the S-Trap manufacturer’s
procedure. The peptide solution was pooled, lyophilized, and desalted prior to nLC–
MS/MS.
Nanoflow Liquid Chromatography Tandem Mass Spectrometry (nLC-MS/MS)
The peptide mixture was separated using a Dionex Ultimate 3000 high-performance
liquid chromatography (HPLC) system (Thermo Fisher Scientific) equipped with a twocolumn setup, consisting of a reversed-phase trap column (Acclaim PepMap100 C18, 5
μm, 100 Å, 300 μm i.d. × 5 mm, Thermo Fisher Scientific) and a reversed-phase
analytical column (30 cm, 75 μm i.d. 360 μm o.d., in-house packed with Pur C18AQ
3 μm; Dr Maisch). Loading buffer was 0.1% trifluoroacetic acid (Merck Millipore) in water.
Buffer A was 0.1% formic acid, and Buffer B was 80% acetonitrile + 0.1% formic acid.
The HPLC was coupled online with an Orbitrap Fusion mass spectrometer (Thermo
Fisher Scientific, San Jose, CA). The gradient was 135 min from 2% to 36% buffer B at a
flow rate of 300 nl/min for GFP-Rab11A samples, and 180 min for whole cell proteome
samples. The MS instrument was controlled by the Xcalibur software (Thermo Fisher
Scientific). The nanoelectrospray ion source (Thermo Fisher Scientific) was used with a
spray voltage of 2.2 kV. The ion transfer tube temperature was 275°C. Data acquisition
was performed in the Orbitrap for precursor ions. MS survey scans were obtained for the
m/z range of 350-1200 in the Orbitrap with maximum ion injection time of 100 ms,
automatic gain control target 5 × 105 and a mass resolution of 120,000. MS/MS was
performed with a TopSpeed duty cycle set to 3 s. Dynamic exclusion was set to 4 sec.
Charge state enabled was 2-6+. Higher Collisional Dissociation (HCD) was set to 30.
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MS/MS was acquired in the ion trap using the Rapid scan mode, an automatic gain
control set to 10,000 and a maximum injection time set to 120 msec.
Proteins Identification and Quantification
The raw mass spectrometer files were processed for protein identification using the
Proteome Discoverer (v2.4, Thermo Fisher Scientific) and the Sequest HT algorithm with
a peptide mass tolerance of 10 ppm, fragment m/z tolerance of 0.25 Da, and a false
discovery rate (FDR) of 1% for proteins and peptides. All peak lists were searched
against the UniProtKB/Swiss-Prot database of Human (January 2020, 20,367 entries)
and UniprotKB/TrEMBL Sendai Virus (Cantell); February 2020, 8 entries) sequences
using the parameters as follows: enzyme, trypsin; maximum missed cleavages, 2; fixed
modification, carbamidomethylation (C); variable modifications, oxidation (M), protein Nterminus acetylation. Protein quantifications were log2 transformed and normalized using
the median of the distribution for each sample. Missing values were imputed using a
distribution of values of 30% width and two standard deviations lower than the average
of the distribution of valid values. Statistical analyses were performed on three different
biological replicates. The sample size was chosen to provide enough statistical power to
apply parametric tests (either homoscedastic or heteroscedastic one-tailed t test,
depending on the statistical value of the F-test; heteroscedastic if F-test p value<0.05).
The t test was considered as valuable statistical test because binary comparisons were
performed, and the number of replicates was limited. No samples were excluded as
outliers (this applies to all proteomics analyses described in this manuscript). Proteins
with t test p value smaller than 0.05 were considered as significantly altered between the
two tested conditions. Data distribution was assumed to be normal, but this was not
formally tested.
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Western Blot
Whole cell lysate (10μg) or immunoprecipitation products were denatured by boiling for
10 min and run on a 4-12% Gradient Bis-Tris Gel (Bio-Rad) before being transferred to a
PVDF membrane (Millipore). Membranes were incubated overnight with primary
antibody in 5% milk. Membranes was incubated secondary antibody for an hour in 5%
milk and developed using Lumi-light western blot substrate (Roche) to detect HRP.
Images were acquired using a ChemDoc biomimager (Bio-Rad) and quantified in
ImageJ. Primary antibodies: rabbit anti-Rab11a (Invitrogen); mouse anti-C (clone p96-6,
a kind gift from Toru Takimoto), chicken anti-SeV polyclonal. Secondary antibodies:
anti-rabbit HRP-conjugated antibody (Cell Signaling), anti-mouse IgG for IP (Abcam),
anti-chicken HRP-conjugated antibody.
RNase Treatment
Post immunoprecipitation unbound fractions or substrate bound to magnetic beads were
subjected to treatment with a combination of 1U/mL RNase A, V, and T1 (Invitrogen) for
15 minutes at room temperature. RNase reaction was stopped by adding Trizol LS
(Invitrogen) to the sample.
RNA Extraction and RT-qPCR
Cellular and viral RNA was harvested using Trizol (Invitrogen). RNA was reverse
transcribed using SuperScript III First Strand Synthesis System (Invitrogen) with OligoDT
for mRNA specific amplification or with primer 5’-GGTGAGGAATCTATACGTTATAC-3’
for viral RNA. qPCR was performed with 1:40 dilution of cDNA, SYBR Green (Life
Technologies) and 5uM forward/reverse primers (Invitrogen) on an Applied Biosystems
ViiA 7 Real-Time System. Relative copy numbers per cell were calculated by delta-delta
Ct and normalized to average cellular GAPDH expression levels. Primer sequences are:
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SeV NP (F: 5’ TGCCCTGGAAGATGAGTTAG-3’ R: 5’-GCCTGTTGGTTTGTGGTAAG 3’); SeV P/C (F: 5’- GGATATCCGAGATCAGGTATTGA-3’ R: 5’GGCCCGGTGTATATTTTGTTT-3’); SeV M F: (5’- GCCATCCCCTACATCAGGAT-3’ R:
5’- GTAACGACCCGGAGCCGCAT-3’); SeV F (F: 5’-CTCCTGAAGATCTCTAAGGCAT3’ R: 5’-GGATCCCACGAATCGAGGTA3’); SeV HN F: (5’GACCAGGAAATAAAGAGTGCA-3’ R: 5’-CGATGTATTGGCATATAGCGT-3’); SeV L (F:
5’- TGGTCAGAGATGCAACGAGA-3’ R: 5’-ACCTTTCAAGGACTGGATGC-3’); gSeV (F:
5’-GACCAGGAAATAAAGAGTGCA-3’, R: 5’-CGATGTATTGGCATATAGCGT-3’), DVG546 (F: 5’-TCCAAGACTATCTTTATCTATGTCC -3’, R: 5’GGTGAGGAATCTATACGTTATAC-3’).
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CHAPTER 4: Conclusions and Future Directions
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4.1 Summary of findings
Defective viral genomes (DVGs) generated during paramyxovirus infections are
able to alter the outcome of these infections primarily by inducing antiviral immunity and
interfering with standard viral genome replication. This dissertation sought to address
how different intracellular localizations of full-length (FL) and defective viral genomes
during Sendai virus (SeV) infection influenced viral infections and asked what these
differential localizations could teach us about paramyxovirus particle assembly. Chapter
2 describes the discrete localizations of SeV DVGs and FL genomes, with genomes in
FL-high cells engaging with Rab11a marked recycling endosomes, and genomes in
DVG-high cells failing to engage with the host in this way. We found that these distinct
interactions contributed to differences in viral particle production with FL-high cells being
the primary producers of both standard and defective viral particles, and DVG-high cells
not contributing to the pool of infectious particles produced during infection(197). In
Chapter 3, we addressed the viral determinants that drive FL-high cells to interact with
Rab11a-containing recycling endosomes. We demonstrated that high levels of viral
polymerase components including L and C, are differentiating factors in cells that
proceed to viral assembly in contrast to DVG-high cells that solely carry out genomic
replication. We propose that C and L proteins are critical in mediating viral genome
engagement with recycling endosomes. Overall, this work has contributed to the
understanding of how DVGs modulate infection outcomes by focusing on differential
particle production in cells, as well as uncovered fundamental aspects of paramyxovirus
assembly. This chapter will discuss broader implications and future directions for these
areas of study.
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4.2 DVG induced heterogeneity
The presence of defective particles during infection leads to heterogeneous
accumulation of viral genomic material in infected cells, with some cells accumulating
predominantly FL genomes (FL-high cells) and others accumulating predominantly
DVGs (DVG-high cells). This type of heterogeneity has been observed for SeV(165) and
described in depth in chapter 2, and has also been observed in influenza (208, 209) and
respiratory syncytial virus(165) infections. The differences in viral product accumulation
results in unique transcriptional responses of the infected cell populations and
corroborates the role of DVGs as strong innate immune agonists. The work presented
here, expands on impacts of this heterogeneity and indicates that the genomic
accumulation influences particle production as well(197). Despite new appreciation that
heterogeneity in DVG accumulation can influence cellular outcomes during infection,
questions remain, including: What viral or cellular factors contribute to the heterogeneity
that is observed? What does this heterogeneity look like in tissue or animals?
4.2.1 Drivers of heterogeneity
During SeV infection with high DVG (HD) stocks of virus, we observed
heterogeneous accumulation of viral genomes amongst infected cells. Though the work
presented here focused on descriptions of DVG-high and FL-high cells, which each
comprise approximately 30% of the infected cell population, there are two other
categories of cells which make up the rest of the population: intermediate cells, which fall
between the phenotype of DVG-high and FL-high cells based on characterization of
vRNA FISH probe binding, and cells with non-detectable (ND) levels of viral RNA based
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on vRNA FISH(165). The factors that impact the distribution of these populations have
yet to be characterized.
We hypothesize that the driving factor for determining a DVG-high or FL-high
phenotype is the ratio of defective particles to standard virions that infect a particular
cell. This hypothesis is supported by the ability to manipulate the proportions of DVGhigh and FL-high cells in an infection by the addition of different amounts of purified
defective particles (pDPs). The addition of increasing amounts of pDPs led to an
increase in DVG-high cells (Figure 2.2). Interestingly, increasing the amount of pDPs
past a certain threshold led to an increase in ND cells (Figure 2.1), suggesting that ND
cells are the product of a single cell receiving an input with a high ratio of DVGs:standard
genome, rather than due to lack of infection, particularly since infections are performed
at an MOI 1.5 to ensure that at least 80% of the cells receive an infectious viral particle.
While the varying ratios of DPs:standard virions that cells receive is likely the
driver of heterogeneity in infection, the precise ratios that lead to the development of
each cell phenotype are not known. Use of new technologies available to more
accurately measure the number of defective particles added to an infection could help
define these ratios. Digital droplet PCR (ddPCR), which allows for quantification of RNA
in the absence of a standard curve, could be used to perform sensitive quantification of
viral RNA on both viral stocks and on purified DPs. In fact, ddPCR methods have been
used to perform sensitive quantification of influenza virus(210) and Nipah virus
DVGs(211), indicating that this would be a suitable method for quantification of DVGs in
purified particle and virus stocks. With the ability to quantify numbers of DVGs in
particles, we could perform infections with varying ratios of purified defective particles
and standard virus and quantify cell populations by RNA FISH coupled with flow
cytometry. These data sets would allow us to calculate the ratio of DPs:standard virions
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that lend to the various cell phenotypes by quantifying ratios of cell phenotypes and
fitting them with Poisson distributions of probability of cells receiving each particle ratio
during infection.
Interestingly, FL-high cells in HD infections harbor DVGs and produce defective
particles at a higher rate than FL-cells in low DVG (LD) infections (unpublished
observation). In LD infections, DVGs must be generated de novo during infection and
DPs are produced at much later timepoints than in HD infections, suggesting that FLhigh cells in HD infections receive defective particles upon infection, but in insufficient
quantities to lead to the development of a DVG-high cell phenotype. This suggests that a
ratio greater than 1:1 DPs:standard virion is required to generate a DVG-high cell, in
contrast to what has been reported for VSV, where even one defective particle was
sufficient to suppress viral particle production(175). The ratios that lead to a DVG-high
cell phenotype may vary in different viral infections or even in infections with the same
standard virus but with different DVG species due to differences in DVG replication
rates. Differences in DVG size or viral promoters may affect the ratios of DPs:standard
that lead to different cell phenotypes.
We have also questioned whether cellular factors influence the development of
DVG-high and FL-high cells during infection. The primary factor that may influence
accumulation of viral products is which stage of the cell cycle cells are in during
infection. Many DNA and RNA viruses employ diverse strategies to promote certain cell
cycle stages to enhance their replication(212). For example, the M2/G stages of the cell
cycle are more permissive to VSV replication(213). Whether cell cycle affects
accumulation of DVGs or FL genomes can be addressed by synchronizing cells to
different phases of the cell cycle prior to infection then performing vRNA-FISH flow
cytometry and quantifying the proportions of DVG-high and FL-high cells generated
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during infections at each phase of the cell cycle. Similar experiments have been done
with picornaviruses and have concluded that different cell cycle phases do not affect the
observed heterogeneity of infection(185). Additionally, given robust evidence that
varying input of defective particles can alter the number of DVG-high cells, we favor the
hypothesis that variations in cell cycle would minimally impact ratios of DVG-high and
FL-high cells.
4.2.2 Heterogeneity in tissue and animal models
The accumulation of heterogenous levels of viral genomes during infection has
primarily been observed in cell culture monolayers with synchronous infections using HD
stocks of virus. An outstanding question is whether these phenotypes will be
recapitulated in vivo. Large bottlenecks during natural transmission of infections mean
that likely very few virions initiate natural infections(144). As discussed in the
introduction, we hypothesize that during initial infection, a single virion seeds a local
focus of infection and that progressive rounds of amplification will eventually lead to
generation of DVGs which will be packaged into DPs. This would create a
microenvironment in which new cells may be infected by standard and defective
particles at varying ratios, eventually recapitulating HD infection phenotypes observed in
vitro. Because SeV is a natural murine pathogen and replicates robustly in the lungs of
infected mice, the question of whether we see this heterogeneity in vivo can be
addressed by performing RNA FISH on lung tissues of infected animals at different
timepoints of infection. Experiments can be performed where mice are infected with SeV
LD and development and expansion of foci of infection can be observed and assessed
for the appearance of DVG-high cells. Mice can also be infected with SeV HD and lungs
can be assayed for the presence of DVG-high cells. Preliminary data from the laboratory
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shows that upon infection of mice with SeV HD, DVG-high cells are identifiable, but they
are low in abundance. The primary issue with performing experiments using RNA-FISH
in vivo has been difficulty in visualizing low levels of signal with high background of
fluorescence in lung tissue, however new strategies to increase intensity of RNA-FISH
probe signals including CLAMP-FISH(214), may be useful in visualizing early events of
viral infection in the lung. Further, techniques to combine RNA-FISH with
immunostaining developed in Chapter 3 could aid in identifying DVG-high populations in
the lung.
The lung is composed of multiple cell types, including type I and type II
pneumocytes that make up the alveoli, as well as structural cells and immune cells such
as resident alveolar macrophages and others(215). During infection with SeV, there is
rapid recruitment of immune cells, predominantly neutrophils followed by T and B cells
required for infection clearance, all of which are able to be infected by SeV(140, 216,
217). Whether heterogeneity of genome accumulation as well as differences in
intracellular distribution of DVGs and genomes, would be observed in different cells
infected in the lung remains to be investigated. The majority of the data presented here
is from infections performed in the tissue culture cell line A549 which are type II
pneumocytes. However, all tissue culture cell lines investigated as well as primary lung
fibroblasts have shown similar heterogeneity and intracellular distribution to that
characterized in A549s. Based on these data, we hypothesize that in vivo pneumocytes
and structural cells would display similar heterogeneity and intracellular distribution as
described here. However, this may not be the case for immune cells. While we have
measured high amounts of viral RNA in neutrophils, and plasmacytoid dendritic cells
(pDCs) are also susceptible to viral infection, these cells are likely not sources of virions.
Therefore, because intracellular distribution of RNA is directly related to virion
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production, we would not expect to see these distinct intracellular distributions in these
cell types. This could be confirmed by using RNA FISH on these cells either in in vivo
tissue slices or by ex vivo cultures and subsequent infections of these cell types. We do
know that DVG replication in pDCs is important for initiation and orchestration of immune
responses(164). Therefore identifying whether different cell types develop DVG-high
cells and whether these cells are the producers of DPs in vivo is important to better
understand the initiation of an immune response.
4.3 Altered Infection Dynamics in the Presence of DVGs
In Chapter 2, we explored how the presence of DVGs alters which cells are able
to produce DPs and standard virions and in Chapter 3, we investigated the impact of
DVGs on interference with viral mRNA expression and viral protein accumulation.
Overall, a better understanding of the dynamics of DVGs influence on infection can help
address larger questions of the impact of DVGs during infection, including: Can we
better model the impact of DVG interference during infection? How can this inform our
models of pathogenesis at a tissue or animal level? How does this understanding impact
the development of DVGs as therapeutics or antivirals?
4.3.1 DVG Impacts on Interference and Pathogenesis
DVGs have been well documented to exert influence on infection through
interference with production of viral proteins through a number of mechanisms, as
illustrated in (Figure 1.4)(92, 218). Competition and viral outgrowth assays in the
presence of DPs have been extensively studied in vitro using VSV to inform
mathematical models. Most often, the presence of DPs delayed, but did not shut down,
viral protein expression in infected cells. Previous models suggested that low levels of
DPs were sufficient to prevent infection(219), but updated models support a multi-hit
105

hypothesis whereby varying levels of input of DPs lead to divergent outcomes of
infection: inhibition of total particle production, limited production of standard virus but
high levels of DPs, and low levels of DPs but high levels of standard virus(220). Yet,
these parameters may change based on the characteristics of the DVGs or standard
virus used for these competition assays. Intriguingly, experiments performed using VSV
found that while small numbers of DPs can completely shut down production of
infectious virus, high levels of DPs prevented this inhibitory effect(175, 186). Further,
virus production can be inhibited with a low input of DPs per infectious virus but cannot
completely eliminate virus production even at very high rates of DPs(174, 221). Gaining
a better understanding of the interplay between standard virus and DVGs at varying
ratios could provide insight for the use of DPs as therapeutic particles or for
understanding how interference modulates pathogenesis in vivo.
The delay in virus production and viral replication induced by DVGs is
hypothesized to increase the time over which virus is produced and perhaps extend
infection(186). Multiple models have been created to help researchers understand how
the inclusion of DPs during infection impacts viral production, as mentioned above, and
limits viral spread(221). However, the production of DPs and how it changes during
infection have not been included in these models, leaving us wondering how these
important aspects of the virus life cycle impact the dynamics. The data presented in
Chapter 2 could aid in the inclusion of DPs in models of multicycle infections and better
represent dynamics of infections in tissues or more complex landscapes.
Further, in chapter 3 we provide a comprehensive investigation into the effects of
interference on the accumulation of multiple viral proteins in a comparative manor. We
show that viral proteins that are least abundant, namely L, are most reduced when
subjected to DVG-mediated interference. Based on our data of mRNA and genome
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amounts over time, we can begin to build more informed mathematical models of viral
replication rates and how the presence of DVGs affect replication and transcription rates.
We have begun to develop mathematical models that reflect how interference by DVGs
may affect protein accumulation and thus viral genome replication and virion production.
Using these models we can vary the amounts of DVGs in the system upon input and ask
how varying levels of DVGs can affect cell fate via interference with certain proteins. We
could also include data from proposed experiments from section 4.2.1 on varying levels
of input DPs, to understand the dynamic range of DPs/DVGs influence on infections. We
can also expand these models to population based models, and combining the data from
Chapter 3 on viral proteins critical for viral particle assembly and the data in Chapter 2
regarding viral particle production during DVG induced heterogeneity, we can begin to
accurately model population dynamics in the presence of DVGs. Building these models
will allow us to better understand the role of DVGs during infection and help guide the
use of therapeutic DVG administration during disease.
4.3.2 Implications for prophylaxis and persistence
Therapeutic administration of DVGs either as a prophylaxis to induce a protective
immune response or as a therapeutic to attenuate replication of virus has begun to be
explored(114, 222-224). Results detailed in Chapter 2 indicate that high levels of
defective particles can generate high percentages of DVG-high cells, and these DVGhigh cells are incapable of generating either defective particles or standard virions. The
inability of these cells to generate standard virions is protective and would achieve the
goals of reducing viral loads by the administration of DVGs or pDPs. In addition, our lab
has demonstrated that DVG-high cells initiate a unique pro-survival transcriptional profile
as a result of MAVS-induced antiviral signaling. This pro-survival program protects these
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cells from TNF-mediated cell death(165). While this work has not been expanded to in
vivo experiments, the concept of cells being protected from cell death and unable to
produce viral particles, seems like it would indeed bolster recovery from viral infection,
as lung damage during respiratory infections is driven by death of infected cells(225).
However, we must also consider the long-appreciated role of DVGs in persistent
infections. DVGs and DPs from many viruses, including paramyxoviruses, have been
associated with the establishment of persistent infections in both tissue culture and
animal models(226). Recently, our lab associated this with the pro-survival pathway
upregulated by DVG-high cells and posited that these DVG-high cells may survive past
the acute phase of infection and act as reservoirs for virus which may become activated
due to immunosuppression or periods of stress later in life(165). Therefore, it is
important to fully understand the dynamics between DVG-high and FL-high cells and
reach an appropriate balance of these cells during prophylactic or therapeutic
administration of DVGs/DPs to maximize disease amelioration and minimize long-term
consequences.
4.4 Paramyxovirus Interactions with Recycling Endosomes During Assembly
In Chapter 3 we suggest that polymerase components, namely the polymerase L
and polymerase cofactor C are important in initiating contact between viral genomes or
viral ribonucleoproteins (vRNPs) and recycling endosomes for the production of
infectious particles. We also explore the role of the matrix protein (M) in regulating viral
assembly. However, there are many areas of this research which should be expanded to
more comprehensively understand the role of polymerase components in paramyxovirus
assembly, including: What molecular characteristics of C protein allow for interaction
with recycling endosomes and how is C protein affected by interference? How is M
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trafficked to the plasma membrane and when does it interact with Rab11a? Which host
proteins are required for vRNP trafficking and how are host cells impacted by viral
assembly? Are the mechanisms described here conserved for other paramyxoviruses?
And what are the implications for these findings in the development of antivirals?
4.4.1. Further characterization of polymerase components required for assembly
Our current model for interactions between vRNPs and Rab11a is that in FL-high
cells when there is accumulation of polymerase to sufficiently high levels, all vRNPs are
occupied by multiple copies of the viral polymerase (approximately 40 copies as
determined by the amount seen on vRNPs recovered from infectious virions)(199, 200).
C protein is covalently attached to L protein(227), presumably acting as a regulator of
polarity of genome replication, favoring production of negative strand genomes at this
time point of infection(31, 73, 119). This C protein is in turn interacting with Rab11a,
either directly or through one another host protein.
Because C proteins are generated from P mRNA, instead of as an independent
gene product, it is not straightforward to generate a virus which does not generate C
proteins without disrupting expression of P. There have been multiple independent
attempts to create a SeV that lacks the four C proteins(72, 228). The SeVΔC virus
generated by the Kolakofsky lab was generated by altering the C and C’ protein start
codons(72). We obtained this virus to test for the involvement of C protein in intracellular
genome localization, however validation in our hands revealed that some version of C
protein was present as a fusion with P protein, as detectable by western blot and
immunofluorescence with an anti-SeV C monoclonal antibody. The Nagai group has also
created a recombinant virus, SeV 4C(-), through the creation of four consecutive stop
codons after all four C proteins(228). We could infect cells with this virus to directly study
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the impact of C proteins on the intracellular localization of viral genomes. I hypothesize
that in the absence of C proteins, viral genomes in FL-high cells will fail to interact with
Rab11a. Indeed, a profound decrease in peak viral titers is observed when cells or
embryonated chicken eggs are infected with 4C(-) viruses(31, 70, 228) and C has been
thus hypothesized to play a role in particle formation(68, 70). If indeed infections with
4C(-) showed defects in vRNP engagement with recycling endosomes, we could identify
which C protein family member which may be essential in interacting with Rab11a, and
further map which regions or residues are essential in this interaction. Paramyxoviruses
tolerate insertion of additional proteins in their genomes, and indeed additional copies of
C have been added to the paramyxovirus genome in the presence of C ablation to
confirm the role of C protein during infection (118). We could create recombinant viruses
that expressed only one C protein at a time and RNA FISH combined with
immunofluorescence could be used to assay for interaction between viral RNA and
Rab11a in the presence of the expression of single C proteins. If a specific C protein is
been identified, similar experiments could be repeated with the insertion of distinct
regions of this C protein or C protein with deletions or mutations and assayed similarly to
identify which regions of C are critical for mediating the interaction with recycling
endosomes. The residues required for C protein to antagonize innate immunity and to
regulate genome polarity have been mapped by mutation (229) and the first 98 amino
acid residues have been deemed dispensable for these functions(230), indicating they
perhaps serve other functions such as bridging interactions between vRNPs and Rab11.
Completing these experiments would further define the interactions of Sendai
virus and the host via its C protein and confirm the role of polymerase components as
essential in regulating the interactions between vRNPs and Rab11a during infection.
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4.4.2 Effects of interference on C proteins
While we were able to measure and compare accumulation of viral RNA over
time in LD and HD infections, we are unable to perform similar measurements for C
because the protein is generated from the P mRNA. Levels of P mRNA are reduced in
HD infections compared to LD infections at 12 hours post infection, but not to a
significantly greater degree than any other viral transcript. We could investigate whether
there are differences in C proteins in FL-high and DVG-high cells. Preliminary data from
immunofluorescence microscopy indicates that there is less C proteins in DVG-high cells
than FL-high cells. We attempted to quantify this using RNA FISH combined with flow
cytometry, but extremely low levels of C proteins are hard to detect by this method. An
alternate strategy would be simply to compare the levels of C proteins by flow cytometry
in SeV LD and SeV HD infections and ask whether levels of C proteins are globally
reduced to the same extent that L proteins are during infection, or whether they are less
significantly reduced similar to the effects on NP proteins. Because P mRNA levels are
not significantly reduced, the levels of C in DVG-high and FL-high cells might be similar.
We do not understand the factors that induce ribosomal skipping or shunting that result
in usage of alternative start codons to produce C proteins. However, it may be that these
fairly rare events cause C levels to be more sensitive to reduced P mRNA levels.
Understanding how alternately translated proteins are affected by interference may shed
light on mechanisms that drive alternate translation of mRNAs during viral infection as
well as add to our understanding of how low abundance proteins are influenced by
interference.
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4.4.3 Further characterization of matrix proteins role in viral assembly
In Chapter 3, we also characterize the role of the viral matrix protein (M) in SeV
assembly. We propose a model whereby L and C proteins are essential in driving
association of vRNPs with Rab11a and that M is trafficked independently and interacts
with vRNPs at the plasma membrane of infected cells. These conclusions rely on the
characterization of the intracellular localization of M at 24 hours post infection, a time of
robust viral particle production. In order to fully characterize the important role that M
plays during infection and fully elucidate where and how it functions during assembly, we
could perform a number of experiments. First, more detailed time courses of M
localization during infection using the already generated recombinant virus would help
clarify when and how M accumulates at the plasma membrane during infection.
Immunofluorescence to detect M via HA tag in combination with other viral proteins such
as C protein could illuminate the sites of their interactions. Additionally, localization of
SeV F or HN proteins and M could be used to determine whether M interacts with these
proteins during trafficking through the trans-golgi network (TGN). Though our results
indicated that SeV M did not have large degrees of colocalization with Rab11a, M is
identified by mass spectrometry to immunoprecipitate with Rab11a. We have yet to
investigate whether we see interactions between M and the TGN, which would support
interactions with cytoplasmic tails of surface proteins during their transit and explain
some level of interaction between M and Rab11a. Further, while time course studies
could help detail the dynamics of M during infection, the creation of a recombinant virus
with a fluorescent protein tag could enhance our ability to study the dynamics of M
during infection. M is an oligomeric protein and does not tolerate a tag at the C-terminal
of the protein and may not tolerate a large tag at the N terminus, but rescue of a virus
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with a GFP or mCherry protein fused to the N-terminus could be attempted using
reverse genetics. Infections using a virus with a fluorescent tagged M protein could be
observed using a spinning-disc confocal over periods of time to observe protein
movement during infection. These infections could also be observed in fluorescently
tagged Rab11a cell lines in order to observer real-time interplay between virus and host
proteins.
Additional experiments to confirm the absence of a role for M in the association
of vRNPs to recycling endosomes could be carried out by creating a virus that lacks M
protein and observing the intracellular localization of vRNPs during infection with this
virus. A single-cycle replication competent virus could be generated that lacks the M
protein in its genome as long as recombinant virus rescue was performed in cells that
stably expressed M protein. This would allow for the creation of virions which could then
be used to infect cells but would not be able to express M protein. In the absence of M
protein, I hypothesize that viral genomes would still interact with Rab11a, confirming the
absence of a role for M in driving this interaction.
Completing these studies would help to understand how matrix functions in
assembly and define the spatiotemporal aspects of its interaction with host cells.
4.4.4 Further characterization of host proteins involved in paramyxovirus assembly
While it is well-established that viral genomes interact with Rab11a to produce
new virions(45, 231), it is still not known whether this is a direct interaction between viral
components and the Rab11a protein itself or whether viral proteins interact with other
host proteins which in turn interact with Rab11a.It has been suggested that viral
genomes may interact with Rab11a family interacting proteins (FIPs) which are a family
of proteins that tether Rab11a to the cell cytoskeleton to direct different types of
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movement. There are five described FIPs which direct different types of motion within
the cell (232). In order to investigate whether any of these FIPs are important in bridging
interactions between vRNPs and Rab11a, we could perform an siRNA screen targeting
the different FIPs. After knock down by siRNA, cells could be infected with SeV LD and
immunofluorescence for NP or vRNA FISH for genomes could be applied to determine
whether perinuclear clustering of viral genomes is disrupted. If there is an observed
change in the localization phenotype in any of the knock down conditions, then this could
indicate that either this FIP is essential for bridging interactions between vRNPs and
Rab11a or that this FIP is necessary for the movement that directs the clustering of
Rab11a at the endocytic recycling compartment during viral infection. Different viruses
have been shown to coopt different FIPs, for example FIP2 has been identified as
important for the production of respiratory syncytial virus virions (53), while budding of
filamentous influenza relies on FIP3(52). In order to investigate whether candidate FIPs
are important for bridging interactions with Rab11a or directing movement of Rab11a,
we could perform colocalization assays of SeV NP and Rab11a during FIP siRNA
knockdowns that yielded changes in localization. If we see decreases in colocalization
between SeV NP and Rab11a during FIP knockdown this indicates that this FIP was
important in bridging the vRNP-Rab11a interaction. If we do not see changes in
colocalization but see changes in Rab11a or NP distribution this indicates that this FIP is
being utilized for Rab11a movement during infection. Performing these experiments
would help to identify elements of host pathways that are coopted during SeV infection
and understand how the virus alters host cell dynamics during infection.
We have also observed that infection with SeV drastically changes the dynamics
of the host cytoskeleton and recycling kinetics (unpublished observations). Drastic
changes in cytoskeleton networks have been observed during infection across many
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types of viruses including DNA, RNA, and retrovirus infections for entry, replication, and
assembly(233). We observe large changes in microtubule dynamics during infection with
SeV LD, decreased transferrin recycling, as well as changes in motor proteins
associated with Rab11a by mass spectrometry. Preliminary experiments have indicated
that disruptions to transferrin recycling are blunted in SeV HD infections compared to
changes seen in SeV LD infections, presumably due to DVG-high cells not disrupting
normal transferrin recycling rates. Finally, mass spectrometry to identify proteins
interacting with Rab11a during infection showed large changes in the proteins that
associate with Rab11a, particularly an increase in proteins that are associated with
membrane trafficking, indicating that the virus alters the cell in a way that promotes
particle production. Changes such as these have been identified in other viruses that
coopt Rab11a pathways during infection, particularly influenza(202, 234). Investigation
into how these proteins and cellular processes are altered during SeV infection could be
pursued to get a more complete picture of how SeV alters normal cell physiology during
infection.
4.4.5 Assembly mechanisms in other paramyxoviruses
While this work has focused on assembly of paramyxoviruses using SeV as a
model, it could be easily expanded to ask whether the principles uncovered in SeV
infection are conserved in other viruses. The first virus that ought to be investigated is
HPIV1 as it is the most closely related human pathogen to SeV. HPIV1 has been
demonstrated to use Rab11a during viral particle formation(47), and HPIV1 expresses C
proteins that have 69% protein identity to Sendai virus C proteins,. They also have
similar described functions in innate immune antagonism (235). Therefore, we could ask
whether HPIV1 C proteins are involved in regulating engagement of vRNPs with Rab11a
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using similar approaches as those described in Chapter 3. Similar to experiments
performed with SeV C proteins, HPIV3 viruses with mutated C proteins have been used
to map residues that are critical for antagonizing the immune response or regulating viral
replication(236), therefore it would be reasonable to carry out similar experiments to
identify residues that are critical for regulating interactions with Rab11a.
In addition to the closely related human parainfluenza viruses which are part of
the respirovirus genus, other paramyxoviruses in the morbillivirus and henipavirus
genuses also encode C proteins that are multifunctional. The C proteins of measles
have been well characterized as interferon antagonists(237) and as polymerase
cofactors that regulate polarity of genome transcription(238, 239). However, the role of
measles virus C proteins in particle production has yet to be investigated. Likewise, the
C proteins of NiV have also been described to be polyfunctional, both acting to enhance
pathogenesis through the antagonism of IFN responses and to participate in enhancing
particle formation(63, 240). The C protein of NiV has been shown to enhance the
recruitment of ESCRT proteins to drive budding in the presence of expression of M(63).
Whether C may also interact with Rab11a in NiV infection is yet to be investigated.
In contrast, viruses in the rubulavirus genus, such as Mumps, do not express C
proteins. While mumps uses Rab11a for particle formation, it differs in requirements of
host proteins during budding, relying on expression of fusion proteins to form VLPs and
is dependent on ESCRT, unlike respiroviruses(65), indicating that there may be different
mechanisms of particle productions used by viruses that do not express C proteins.
Members of the avulavirus genus such as NDV also do not express C proteins. There
are no reports on whether NDV requires Rab11a for particle formation, but there is
evidence that VLP formation requires expression of F and HN for homogenous particle
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formation like for mumps(241), arguing that these viruses have different requirements for
particle formation than those that express C proteins.
4.4.6 Implications for development of therapeutics/antivirals
Completion of experiments detailed above will help to elucidate the molecular
mechanisms of paramyxovirus assembly. With a better understanding of how viral
proteins interact to assemble particles, we can develop virus directed small molecules to
that prevent the virus from interacting with the host. Identifying residues and regions of C
proteins in SeV that are critical for regulating these interactions is useful for identifying
whether there are conserved regions in C proteins that behave similarly across
paramyxovirus species or genuses. Further, completing more detailed studies of the role
of M in SeV infection will help to elucidate a previously contested role of this viral protein
in assembly. A better and more nuanced understanding of this proteins’ role in viral
assembly will be helpful in the development of antiviral drugs, since, as an oligomeric
protein, it may be efficiently targeted(242). Additionally, having a better understanding of
proteins in the host that are manipulated by the virus could give rise to host directed
therapies that may be more broadly acting than virus directed therapies.
4.5 Concluding Remarks
Overall this work provides a better understanding of how DVG induced
heterogeneity contributes to viral population dynamics. These insights can be used to
better understand complex interactions between virus, DVG, and the host and model
viral infections in tissues, as well as inform uses of defective particles as prophylactics or
therapeutic interventions. Additionally, this work uses DVGs as a tool to expand our
knowledge on basic paramyxovirus biology and understand critical elements that drive
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viral genome assembly. The identification of viral polymerase components as critical for
virion assembly provides additional targets for antiviral therapy.
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